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NEUROGENESIS IN THE ENTERIC NERVOUS SYSTEM: 
UNCOVERING NEUROGENIC POTENTIAL THROUGH INDUCIBLE MODELS 
MALIE KAWILA COLLINS 
ABSTRACT 
Great strides have been made with regard to neurogenesis in the enteric nervous 
system (ENS), rapidly following in the wake of recent revelations about the 
neurogenic properties of the central nervous system (CNS). As the ENS is more 
exposed, highly complex, and vulnerable to a variety of developmental, acquired, 
and multisystemic disorders, there is a sense of urgency for studies to address 
the potential within the gut to restore neurons that are injured or lost. It is the 
intricacies of the ENS and yet unclear relationships between agonists and 
embryonic precursors that have made demonstrating the arrival of new neurons 
in mature gut difficult under steady-state conditions.  
This thesis demonstrates that inducible models of a wide range of insults to the 
gut have yielded crucial information about ENS neurogenesis, while in vivo 
experimentation under steady-state conditions has proven inconsistent. 
Specifically, the signaling pathways of Ret and PTEN have revealed the 
existence of a ‘natural block’ that normally regulates neurogenesis and keeps 
proliferation well controlled. Furthermore, the overwhelming effects of serotonin 
agonism on neuron density in response to injury have uncovered an essential 
role of neuronal transdifferentiation by enteric glial cells that extends beyond 
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what was once understood to be a largely homeostatic role. The influence of 
extrinsic innervation of the gut will also be explored, physiology of which is 
important for both the utility of gut microbiota and the role of Schwann cell 
progenitors in the development of the ENS. 
Therefore, this thesis will outline ENS organization and function, as well as 
describe common pathologies that serve as the foundation upon which 
neurogenesis is investigated. Critical inducible models to which chemical and 
molecular agonists are applied will be examined in detail, as it is through these 
models that therapeutics and biomedical engineering can be optimized in order 
to correct the pathophysiology of enteric neuropathies that as of now are still 
treated with surgical intervention. 
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INTRODUCTION 
Recent interest in the neurogenic potential of the enteric nervous system stems 
not only from the importance of the physiological function of the gastrointestinal 
tract, but the pathophysiology that arises due to mechanical, chemical, or 
metabolic insult. Discovering the mechanisms behind damage and repair of 
enteric neurons can shed light on novel therapeutics and tissue engineering, as 
well as refine the mode of treatment for genetic and acquired enteric 
neuropathies. As some characteristics of the central nervous system may be 
analogous to those of the enteric nervous system, studies of the innervation of 
the gut may in turn be applicable beyond the enteric and peripheral nervous 
systems. In this first part of the thesis, the fundamentals of the enteric nervous 
system are described, including the embryology and differentiation of neural 
progenitors to build the framework for postnatal neurogenesis. Also reviewed are 
disease states that serve as the pathology upon which many neurogenesis 
studies are founded.  
ENS Structure, Organization, and Function 
The enteric nervous system (ENS) is by far the largest and most complex 
network within the autonomic nervous system (ANS), composed of neurons and 
glial cells that form interconnected ganglia innervating the gut wall. The ENS 
comprises concentric layers known as the outer myenteric or Auerbach's plexus 
(MP) and the inner submucosal or Meissner's plexus (SMP) as diagrammed in 
Figure 1 (Furness, 2006). Embryologically, the myenteric plexus is formed first 
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and extends throughout the entire gastrointestinal (GI) tract situated between 
longitudinal and circular smooth muscle (Jiang et al., 2003). The submucosal 
plexus associates with the connective tissue between the circular smooth muscle 
and innermost mucosa of the gut. Small mammals have a submucosal plexus 
restricted to the bowel, but humans and large mammals have a gastric 
submucosal plexus containing scant cell bodies and nerve fibers. Generally, the 
myenteric ganglia are larger than the submucosal ganglia within a given segment 
(Furness, 2006). Though there is some evidence that suggests there may be a 
third ganglionated plexus of the ENS in the intestinal mucosa, this report will 
primarily focus on the MP and SMP (Fang et al., 1993; Balemba et al., 2002; 
Metzger et al., 2009).  
 
Figure 1:  Organization of the enteric nervous system and associated muscle layers. The 
enteric nervous system is composed of two major plexuses, one submucosal plexus and one 
myenteric plexus located between the circular and longitudinal smooth muscle layers. These 
neurons relay electrical signals between the GI tract and central nervous system. [Adapted from 
http://clinicalgate.com/gastrointestinal-hormones-and-neurotransmitters/] 
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Given the internal structure, organization, and chemical markers of the ENS, it is 
more evocative of the central nervous system (CNS) than other regions of the 
peripheral nervous system (PNS) to which it belongs, hence the perception that 
the ENS is the "Little Brain" of the gut (Gershon, 1999; Wood & Grundy, 1998). A 
fully mature ENS develops within days of birth and has autonomic capabilities, 
able to control GI behavior such as peristalsis and secretory activity without CNS 
input (Ruhl, 2005; Gershon & Tack, 2007). The ENS is joined to the CNS via 
sympathetic and parasympathetic sensorimotor pathways, as the CNS 
connection is necessary for fine-tuning the functions of the ENS. In order to 
achieve coordinated GI motility, there must be a functional interaction between 
the smooth muscle of the gut and the interstitial cells of Cajal (ICCs, or gut 
pacemaker cells), which produce the slow electrical waves that initiate peristalsis. 
ICCs are closely associated with the neurons of the ENS but are not part of the 
ENS itself (Burns, 2005; 2007). Additionally, these cells along with mast cells 
comprise the neuro-immune axis that maintains mucosal immunity and affects 
epithelial stem cells of the intestinal mucosa, thereby influencing epithelial 
integrity (Bjerknes & Cheng, 2001; Toumi et al., 2003). While the CNS is fortified 
due to the blood-brain barrier, the ENS is apposed to a luminal surface that is 
perpetually in contact with toxins, bacteria, and other microorganisms; therefore, 
maintenance of the epithelium is paramount. The ENS also regulates blood 
supply to the GI tract and serves as the relay point between neural and 
endocrine pathways along the gut-brain axis (Furness, 2006; Collins et al., 2012). 
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As a result of the interdependency of other bodily systems and the ENS, small 
changes in enteric neural pathways can have drastic implications that mirror 
injuries to the CNS. 
The number of neurons in the ENS equates and possibly surpasses that of the 
spinal cord, in the hundreds of millions (Furness & Costa, 1987). Intrinsic primary 
afferent neurons (IPANs) in both the myenteric and submucosal plexuses 
monitor the gut lumen and alterations of the gut wall, ascending and descending 
interneurons connect neurons and ganglia to each other, and inhibitory and 
excitatory motor neurons target smooth muscle cells. There are two main 
morphologies of neurons, the Dogiel type I and II; type I neurons have numerous 
short processes and one long process, whereas type II neurons are multipolar 
with many long processes (Furness, 2000). Morphology was an early method of 
classifying ENS neurons, and they can also be characterized by 
electrophysiological potential termed after-hyperpolarizing (AH) or synaptic (S) 
neurons depending on the duration and amplitude of their action 
potential/hyperpolarization (Furness, 2000). The most common and useful 
method of subtype identification, however, is by surface markers, nuclear 
receptors, or cytoplasmic staining that are associated with particular stages of 
differentiation. Different types of neurons arise at distinct developmental stages 
and some neurons only appear in the postnatal period (Branchek & Gershon, 
1989; Matini et al., 1997; Vannucchi & Faussone-Pellegrini, 1996). 
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In addition to these clusters of neuronal cells, the ENS is made up of glial cells 
that surround the neurons and are fundamental for proper organization and 
function of the ENS (Verkhrastsky & Butt, 2007). These cells exceed neurons in 
number and resemble the astrocytes of the CNS, but are unlike the Schwann 
cells of the PNS in that they do not form basal laminae nor myelinate axons as 
individual cells (Gershon & Rothman, 1991). Glia support the neurons by 
providing nourishment, regulating synaptic transmission, maintaining the 
intestinal-epithelial barrier, and linking communication between the nervous and 
immune systems (Clarke & Barres, 2013; Alvarez et al., 2013; Jensen et al., 
2013). Multidirectional cellular interaction with the mesenchyme, immune cells, 
and epithelial cells maintain the integrity of the mucosal barrier and without these 
cells, various inflammatory, developmental, and degenerative ailments may arise 
(Ruhl, 2005; Skaper et al., 2014). Enteric glial cells have proven essential to ENS 
neurogenesis as will be detailed in this thesis. 
ENS Origin, Development, and Differentiation 
Early in the development of the ENS and soon after the foregut mesenchyme is 
invaded by enteric neural crest stem cells (eNCSCs), enteric neurons appear and 
can be identified via detection of pan-neuronal markers (Baetge & Gershon, 
1989; Young et al., 1999). The eNCSCs are multipotent stem cells and a 
transient part of the ectoderm that exists throughout embryonic neurulation (Le 
Douarin & Teillet, 1973). In processes that are controlled by molecular gradients 
of bone morphogenic protein (BMP), Notch, fibroblast growth factors (FGFs), and 
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Wnt pathways, neural crest cells (NCCs) delaminate from the epithelium and 
move away from the dorsal neural tube (Metzger, 2010). NCCs follow a defined 
route through the embryo into various epithelial and mesenchymal cellular 
groups that include neural cells of the ANS, mesenchymal cells in the head, 
adrenal chromaffin cells, and melanocytes of the skin (Le Douarin, 1980). The 
gut is colonized ventrolaterally then ventromedially along the dorsal aorta 
towards the proximal foregut, with the vagal neural crest defined as the axial 
origin of most eNCSCs (Le Douarin & Teillet, 1973). The whole embryonic gut is 
colonized via the foregut mesenchyme with cells from the vagal and truncal 
regions, while some eNCSCs originate from the sacral region of the neural tube 
to colonize the hindgut (Heanue & Pachnis, 2007; Burns & LeDouarin, 1998). 
The highly conserved rostral to caudal emigration pattern is influenced by the 
RET/GFRa1/GDNF signaling pathway as well as endothelin-3(EDN3)/endothelin 
receptor B (EDNRB) signaling, neurotrophins and associated growth factors, 
guidance molecules such as semaphorins, and transcription factors such as 
Sox10, Phox2b, Pax3, and Mash1, among others (Heanue & Pachnis, 2007). 
Vagal NCC gut colonization is complete around e15 in mice and after 
approximately seven weeks gestation in humans (Jiang et al, 2003; Druckenbrod 
& Epstein, 2005), however the ENS is not yet completely developed (Rauch et 
al., 2006). Markers for the enteric neuron transcription factors are widely used for 
cellular identification.  
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Undifferentiated NCCs are first characterized by high expression of Sox10, an 
SRY-related HMG-box gene (Paratore et al., 2002; Kim et al., 2003). As the 
number of NCCs increases during colonization, genes for progenitor markers 
such as Mash1, p75, Ret, Phox2b, and Nestin are upregulated and as a result 
the NCCs become further committed (Young et al., 2003; 2004). They then 
become positive for HuC/D, PGP9.5, and β-tubulin III, which are expressed by 
neurons but not glial cells. Alternatively, eNCSCs can differentiate into committed 
glial cells that become positive for Sox10, S100, and B-FABP) (Ruhl, 2005). 
There are some shared markers between eNCSCs and the glial lineage such as 
Sox10, EdnrB, and Notch (Paratore et al., 2002; Okamura & Saga, 2008). While 
glia share some of the same markers and have been shown to be neurogenic in 
vitro, in vivo the evidence is not as strong. There is some indication that a small 
population of glial cells is able to divide and demonstrate further plasticity in the 
postnatal gut when pathology arises, including inflammation and degradation, 
which is observed through the upregulation of the neurotrophic factors GDNF, 
NGF, and others as well as the expression of neural stem cell markers such as 
Nestin and GFAP (von Boyen et al., 2004; Schafer et al., 2009). These cell 
markers are vital to the study of neural proliferation, particularly in the context of 
inducible injury and genetic modeling. 
The ENS: Reminiscent of the CNS 
The relevance of the central nervous system may extend beyond its influence 
over the autonomic nervous system; parallels between the glia and neural stem 
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cells of the CNS have served as the starting point for much of the investigation 
into the ENS. Only a little more than a decade has passed since neurogenesis in 
the CNS was found to continue after birth. Mammalian and human studies have 
confirmed the persistence of adult stem cells, once classified as astrocytes, 
within the hippocampus and olfactory bulb/subventricular zone (Kriegstein & 
Alvarez-Buylla, 2009). The common origin of glia and neuronal cells was further 
expounded when this subpopulation of astrocytes was administered appropriate 
stimulation, as the neural stem cells were able to differentiate into neurons and 
glia both in vitro and in vivo (Reynolds & Weiss, 1992). Furthermore, many of the 
neuronal subtypes and neurotransmitters of the ENS can also be found in the 
CNS (Furness, 2006). The discovery of this CNS stem cell niche thus highlighted 
the possibility of a similar postnatal stem cell niche in ENS. As some of these 
neuronal subtypes, such as CGRP, first appear in the late fetal stages and even 
in the postnatal stage, ongoing postnatal neurogenesis became a possibility 
(Young et al., 2003).  
Additionally, the CNS and ENS may be similar when it comes to pathologic 
changes. Dysfunction of the GI tract is not uncommon, and some of the dominant 
symptoms of CNS diseases such as Parkinson's include dysphagia, constipation, 
and inadequate gastric emptying. In these cases, it is likely that cerebral 
degeneration occurs along with degeneration of the ENS myenteric plexus 
(Martignoni et al., 1995; Pfeiffer, 1998; Lebouvier et al., 2009). However, unlike 
the CNS, the ENS is highly susceptible to injury and is exposed to pathogens, 
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toxins, and allergens that threaten the ENS on a daily basis. It is not surprising, 
therefore, that 10-20% of adults suffer from diseases of the ENS, particularly 
irritable bowel syndrome (IBS; Ehrenpreis, 2005).  
Disease States 
The ENS monitors the fundamental actions of the gut wall, and therefore when 
the ENS is negatively affected, GI dysfunction will arise to a corresponding 
degree. The largest proportion of digestive disease stems from enteric 
neuropathies that can be congenital or acquired as the result of a systemic 
disease, symptoms of which can range from minute changes in the cellular 
composition of ganglia or enteric connectivity to absolute aganglionosis of 
portions of bowel (Di Nardo et al., 2008; Furness, 2008). The following sections 
detail disorders of the GI tract that are associated with ENS perturbations and 
serve as the context for neurogenesis research. 
Congenital and Developmental Disturbances  
The most common identifiable congenital disorder of the ENS is Hirschprung's 
disease (HSCR) with an incidence of approximately one in 4500 live births 
(Newgreen & Young, 2002). HSCR is caused by disturbances that develop 
during the formation of the ENS, which leads to an absence of enteric ganglia at 
variable lengths. It is primarily associated with aganglionosis in the most distal 
part of the intestine (Chakravarti, 2001). Peristaltic movements are dysregulated 
by a tonic contraction of the aganglionic segment, leading to a functional 
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intestinal obstruction. This is frequently complicated by enterocolitis as well as 
massive distension of the proximal bowel, termed megacolon. Soon after birth, 
symptoms such as vomiting and failure to pass meconium (an infant’s first stool) 
indicate this functional obstruction (Swenson, 2002). The genetic disorder is 
heterogeneous in nature and can be either familial or sporadic; the Ret tyrosine 
kinase receptor gene (Ret) is the principle causative gene with a 50% mutation 
frequency in familial cases and a 15-35% frequency in sporadic cases (Hofstra et 
al., 2000). The extent of aganglionosis is correlated with two types of HSCR, 
short-segment HSCR (S-HSCR) and long-segment HSCR (L-HSCR), and 80% of 
cases are sporadic S-HSCR. Familial HSCR is influenced by gender with a male 
to female ratio of four to one (Swenson, 2002). HSCR represents a life-
threatening obstruction with severe or total aganglionosis and is currently treated 
with artificial nutrition, small intestinal transplantation, or surgical resection of the 
aganglionic segment.  
Another congenital disorder is intestinal neuronal dysplasia type B (INDB), but it 
is less clinically defined. Due to interrelated neurologic injuries between the CNS 
and ENS, it is postulated that the nervous systems may share similar injury 
response mechanisms. For instance, in the brain, inflammatory cells secrete 
neurotrophic factors—brain-derived neurotrophic factor (BDNF) and glial cell line-
derived neurotrophic factor (GDNF)—which promote nerve growth (Batchelor et 
al., 2000). It is possible that the hyperplasia seen in INDB is due to a similar 
mechanism. INDB is functionally consistent with improper formation of the ENS 
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during development. Hyperplasia manifests as an increase in the number of 
neurons per submucosal ganglion, submucosal neurons, and ectopic ganglia in 
the muscularis mucosae and lamina propria (Meier-Ruge et al, 2004). While 
hypo-ganglionosis can effect peristalsis, hyperplasia also negatively influences 
proper bowel function. Both a loss and an increase in the number of neurons can 
cause GI dysfunction, and therefore understanding the mechanism underpinning 
ENS neurogenesis can potentially relieve diseases that are characterized by 
hyperplasia, as certain aspects of the neurogenic process could be abrogated. 
Acquired and Age-Related Enteric Neurodegeneration 
The number of enteric neurons increases throughout development, continuing in 
the postnatal period (Liu et al., 2009). Unlike neuronal precursors, neuroblasts of 
the ENS continue dividing after pan-neuronal markers are expressed (Baetge et 
al., 1990; Young et al, 2005). Therefore, a neuron is classified as an enteric 
neuron when its neuronal precursor exits the cell cycle. The degeneration of 
these neurons is defined as either a secondary effect of primary pathological 
conditions or as idiopathic (Firth & Prather, 2002; Wade & Cowen, 2004). Studies 
of both human and murine ENS show age-related reduction in the number of 
neurons mediated by the immune system. This occurs primarily within the 
myenteric plexus, and typically manifests as abnormal ganglia structure or nerve 
fiber density (deSouza et al., 1993; El-Salhy et al., 1999; Philips & Powley, 
2007). Fiber density is one means of comparing inducible injury to the steady-
state, as will be seen in the studies reviewed. The reduction of neurotransmitter 
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expression or distinct neuronal subtypes has been correlated with alterations in 
the ENS (Feher & Penzes, 1987; van Ginneken et al., 2001; Wade, 2002). The 
vulnerability of specific cells is still unclear, but the same neurodegenerative 
processes of the CNS—including oxidative stress by reactive oxygen species 
(ROS)—have been linked to ENS degeneration as well (Thrasivoulou et al., 
2006; Wade & Cowen, 2004).  Alterations such as these lead to diseases 
including achalasia (lack of relaxation in the lower esophageal sphincter), pyloric 
stenosis (narrowing of the duodenum), and gastroparesis (delayed gastric 
emptying). Symptoms of GI distress include dysphagia, reflux, abdominal pain, 
and fecal incontinence (De Giorgio et al., 2004; Di Nardo et al., 2008). Certain 
multisystem diseases such as diabetes, as well as gut inflammation and 
infection, are associated with neurodegeneration (Collins, 1996; Mawe et al., 
2004; Chandrasekharan & Srinivasan, 2007). Effects include increased size and 
number of nerve bundles, activation of glia, and altered neuropeptide and 
neurotrophin release (Geboes & Collins, 1998; Cabarrocas et al., 2003; von 
Boyen, 2004; Margolis & Gershon, 2009). The severe aganglionosis found in the 
murine gut as a result of hemorrhagic necrosis and eroded mucosal integrity 
hints to a role in the inflammatory process (Bush et al., 1998; Ruhl, 2005). The 
overall manifestations of enteric disorders have clearly been observed, however 
the pathways behind them are more difficult to discern. 
Unlike other subsets of the nervous system, the ENS undergoes non-
pathological neurodegeneration associated with age that occurs in both the 
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myenteric and submucosal plexus (de Souza et al., 1993). Neurodegeneration of 
the myenteric plexus in 12-month-old animals was found to be linear in rate and 
influenced by diet, an area that will be discussed further in this thesis as it 
pertains to gut microbiota (Phillips & Powley, 2001; Cowen et al., 2000). Age-
related neuronal loss is also associated with an increase in intraneuronal levels 
of ROS due to diminished neurotrophic factors (Thrasivoulou et al., 2006). These 
factors, such as GDNF, reduce ROS levels in order to protect neurons against 
ROS-induced cell death, an effect of which is magnified when diet is restricted. 
However, it is important to note that age-related neurodegeneration affects 
certain neuronal subtypes more than others; neuronal loss in the myenteric 
plexus selectively affects cholinergic neurons but not nitrergic neurons, which are 
more affected in gastroparesis and achalasia (Phillips et al., 2003). 
Gastrointestinal function can be diminished as a result of these changes and 
might explain disorders than regularly affect the elderly. 
Nondevelopmental Neurodegeneration: Inflammation 
Irritable bowel syndrome (IBS) is a functional disorder of the gut in which the 
sensory nerve fibers become hyperactive and bowel motility is disrupted 
(Canilleri & Choi, 1997; Drossman, 1999). IBS may be characterized by 
constipation, diarrhea, or both. There is no clear objective sign or pathologic 
marker of the disease, and currently diagnosis is symptom-defined after 
excluding other conditions. Although it is not an inflammatory disease, the 
incidence of IBS increases following an episode of inflammation, and post-
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infectious IBS is a recognized subtype of IBS (Neal et al., 1997; Spiller, 2003). 
Neuromuscular dysfunction persists long after the inflammation dissipates and 
thus may contribute to the IBS (Sharkey & Kroese, 2001). Inflammation may 
therefore cause long-term changes in not only neuronal function but also change 
the phenotype and population density of the neurons. Inflammatory bowel 
disease (IBD) in general includes Crohn's disease and ulcerative colitis. In 
Crohn's disease, just as in IBS, the sensory nerve fibers are hyperplastic and 
there is hypertrophy of the neurons. However, acute colitis results in neuronal 
loss and patients experience a proliferation of the glial cells in response to the 
inflammation (Lin et al., 2005; Bradley et al., 1997). Each of these will be 
reviewed in the studies that follow, as models with injury to gut have revealed 
novel roles of enteric glial cells in inflammation and the dynamic changes that 
occur in the enteric plexuses. 
Specific Aims 
The aims of this thesis include: 
1. Comprehensive review of the challenges of observing ENS neurogenesis 
under steady-state conditions, and the ways in which researchers have 
sought to overcome these challenges. 
2. Analysis of the current evidence for the mechanism of neurogenesis, the 
extent to which it occurs, factors mitigating or enhancing ENS response, 
and cellular origins for new neurons. 
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3. Conclusions on the value and validity of experiments using inducible injury 
and genetic models as well as receptor agonism as it pertains to 
neurogenic proliferation in the enteric nervous system. 
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STEADY-STATE ENTERIC NEUROGENESIS 
Initially, research concerning neurogenesis in the ENS focused on the timeline of 
neuronal maturation to delineate baseline neuronal differentiation and outline 
experimental methods that would later aid in the identification of neurogenic 
mechanisms. For instance, Pham et al. sought to determine the birth-date of 
various subtypes of enteric neurons by using a pulse-chase method of titrated 
thymidine to label nuclei. It was found that the maturation of different types of 
neurons overlap with a long window in which each subtype exits the cell cycle—
thus the differentiation of one class could affect the formation of subsequent 
classes (1991). Chalazonitis et al. further concluded that myenteric subclasses 
are all born prenatally with the exception of VIP- and CGRP (calcitonin)-
expressing neurons that arrive within the first postnatal weeks, which suggests 
that neurons are added to the ENS postnatally even after the gut has become 
functional and long after embryogenesis (2008). This introduced avenues in 
which neurogenesis could be further explored, as it raised the question as to how 
the neurogenic potential of eNCSCs shifts throughout ENS development. 
ENS Neurogenesis in vivo: A Challenging Observation 
In 2011, a robust study by Joseph et al. assessed neurogenesis in a vast array of 
induced injuries to the GI tract. The foundation for their research was the 
analogous adult CNS, as studies found that neurogenesis could be triggered in 
the olfactory bulb by odorant enrichment and in the dentate gyrus by exercise, 
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injury, and hormones (Altman, 1969). Additionally, preliminary studies showed 
that ENS neurogenesis in steady-state conditions had not been clearly observed 
in adult mice, though BrdU incorporation was detected after exogenous 5-
hydroxytreyptamine receptor 4 (5-HT4R; serotonin) was administered (Liu et al., 
2009). Thus, Joseph et al. expanded on the pattern of triggered or stimulated 
neurogenesis in an attempt to observe ENS neurogenesis in vivo. 
The study identified CD49b+ cells that express a number of shared eNCSC 
and/or enteric glial markers and the morphology and localization of myenteric 
glia, as well as defined characteristics of enteric glia such as p75, GFAP, S100β, 
and Sox10 expression (Joseph et al., 2011). These cells were used to test 
whether new neurons or glia would develop in the gut under various physiological 
conditions such as aging, pregnancy, changes in diet, hyperglycemia, and 
exercise. Injuries to the gut were also examined such as inflammation, partial gut 
stenosis, and glial ablation. Additionally, dividing progenitors were marked with 
the thymidine analog BrdU injected into rodents under steady-state conditions. 
BrdU infusion is a common method utilized by many studies as a reliable way to 
identify new neurons: any neurons containing BrdU would indicate that these 
cells had recently proliferated, thus providing evidence that they had newly arisen 
from a progenitor. 
BrdU injection was combined with pan-neuronal marker HuC/D 
immunofluorescent staining under steady-state conditions to identify recently 
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proliferated neurons. Joseph et al. analyzed a total of 108 rats and 51 mice—a 
notably high N value—using brain matter as the control tissue throughout. Enteric 
neurons specifically were identified by their location and morphology in addition 
to staining. Neurogenesis was observed in the dentate gyrus of every rat with the 
detection of BrdU+ neurons, however BrdU+HuC/D+ ENS neurons were detected 
in only a single rat. This single male rate had been treated with a surfactant, 
benzalkonium chloride (BAC), which is an established ENS injury model. 
Although 6.1% of HuC/D+ neurons in the injured region of the gut were BrdU+ in 
comparison to 4.7% of neurons in an uninjured region 1 cm away, Joseph et al. 
was unable to replicate this evidence of neurogenesis, the circumstances of 
which were already greatly restricted. Researchers even used osmotic 
minipumps to supply the cells with growth factors that might stimulate 
neurogenesis, but to no avail. Furthermore, neurogenesis was not observed in 
healthy, normal ENS five months after treatment. Therefore, the data suggests 
that neurogenesis does not typically occur in steady-state conditions in the adult 
gut, or that neurogenesis occurs by means that were not detected through cell 
division as was studied by Joseph et al. Although adult enteric glia in culture 
have been shown to form neurons and glia, it is notable that gliogenesis was 
readily observed in vivo in both steady-state conditions and post-injury; 
BrdU+S100β+ glia were found in the myenteric plexus following inflammation 
(Joseph et al., 2011). Due to the difficulty of observing neurogenesis in vivo, 
early conclusions described adult ENS neurogenesis as unreproducible in 
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comparison to the readily observable gliogenesis, or to the neurogenesis of the 
CNS. 
Modifying the Optical Technique 
Utilizing a different imaging technique to visualize neurogenesis in the ENS is 
one way to address the difficulty of observing neurogenesis in vivo. Traditional 
fluorescence or confocal microscopy is limited, and in vivo imaging would ideally 
require greater depth whilst maintaining high resolution and quality. In the ENS 
this ability is of even greater importance because, unlike brain tissue, the gut 
consists of numerous layers and tissue types in addition to the blood vessels, 
muscle, and crypt glands. Granulation tissue, or the new connective tissue 
formed by fibroblast growth and invading blood capillaries, is formed after tissue 
injury and is about 300-400 µm thick, and therefore nonlinear optical microscopy 
is advantageous for ex vivo and in vivo preparations. Goto et al. sought to 
perform two-photon microscopy (2PM) in a novel application for imaging impaired 
enteric neural circuits within thick granulation tissue in the ileum of Thy1 
promoter mice (Figure 2; 2013). These mice express cytoplasmic green 
fluorescent protein (GFP) in enteric neurons. The 3-dimensional reconstructions 
would allow for greater depth of imaging and hopefully reveal any newly 
generated enteric neurons. 
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Figure 2: Apparatus for 2PM imaging in vivo. The anastomosed region of the living ileum can 
be observed while maintaining vascularization and a consistent luminal environment. [Adapted 
from Goto et al., 2013] 
Goto et al. used a transgenic mouse with sparse expression of GFP in thalamic 
and cortical pyramidal neurons, inducing a gut injury by transecting 5-6 cm from 
the ileo-cecal sphincter followed by a one-layer anastomosis (2013). The 
resulting granulation tissue is thick, as shown in Figure 3. Following 2PM 
imaging, the z-stack images obtained consisted of 100-300 optical sections taken 
1 µm apart within 400 µm of the serosal surface. With this technique, the enteric 
neurons of the intact, uninjured terminal ileum were observed in the mucosa, 
submucosa, SMP and MP, and both the circular and longitudinal muscle layers. 
Although the normal mouse gut was thin, images stacked with a Z-axis depth up 
to 50 µm had a very low signal to background fluorescence intensity ratio. 
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Figure 3: Thick granulation tissue at the anastomotic region in a mouse treated with MOS 
solution for 1 week after anastomosis surgery. Panel B is a hematoxylin- and eosin-stained 
microscopic image of a longitudinal section that was taken along the dashed line indicated in 
panel A. The thickness of the tissue presents an issue for imaging neuronal proliferation. 
[Adapted from Goto et al., 2013] 
Neurogenesis was promoted with a 5-HT4 receptor agonist, mosapride citrate 
(MOS), as 5-HT4 receptor-mediated neuroprotection and neurogenesis has been 
demonstrated in the ENS of adult mice (Liu et al., 2009). This was further 
affirmed by treatment with a 5-HT4 receptor antagonist, which completely 
hindered the effects of MOS on neurogenesis. Multiple methods of imaging were 
used as a comparison for 2PM images, including stereomicroscopic imaging 
which did not reveal nerve cells or fibers in the anastomosed region of the gut. 
The same was true for confocal images of the fixed whole mount preparation. 
2PM imaging seemed to reveal new neuronal development in the anastomosis, 
but overall, in the various groups Goto et al. tested, all neurons were reported to 
be located within 100 µm of the surface of the tissue. New neurons were BrdU+ 
and GFP+, but surprisingly GFAP+ enteric glial cells were not found. Moreover, 
these results contrast the observation that neurons were found much deeper and 
regardless of depth in healthy control tissue in vivo.  
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While the 2PM images demonstrated a large amount of neurons near the 
anastomotic site, the presumption that these neurons were newly proliferated 
was not sufficiently supported with 2PM imaging. In order to provide more 
evidence of new neurons, Goto et al. cut sections from the anastomosis for 
immunohistochemical staining (IHC), but a limitation of IHC is the inability to 
perform a true co-stain. Consequently, each consecutive section was stained 
differently, one specifically for neurons and a subsequent section for BrdU. 
Though it is possible to line up the images taken from each section to identify 
which cells stained for both cell markers, this is not true co-localization and 
therefore there is an inherent risk of misidentification. Therefore, while 2PM 
imaging allows researchers to explore to greater depths within thick tissue, 
evidence of neurogenesis in vivo in this study can only be suggested by the data 
provided. 
Sox10 Expression: Genetic Regulation of Neurogenesis 
Although the study of ENS neurogenesis in vivo has yielded variable results 
across multiple methods, cell culture in vitro is still of great value to researchers. 
While evidence for 5-HT4-mediated neurogenesis and the effects of other injury 
models are reviewed in this report, such as inflammation and experimental 
obstruction that increases the number of neurons in the gut, a large part of the 
relationship between these factors and embryonic precursors is unclear.  
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In vitro studies of one such factor, Sox10, is associated with embryonic 
neurogenesis as undifferentiated Sox10-expressing progenitors are capable of 
producing enteric neurons and glia in the embryonic gut. Sox10 is detected in 
eNCSCs that delaminate from the neural tube and ultimately invade the gut 
(Anderson et al., 2006). In an in vivo approach to the in vitro studies of Sox10, 
genetic fate mapping was combined with cultures of dissociated ganglia and an 
injury model with the aim of identifying ENS progenitors and tracing their 
development. 
In agreement with previous studies, Laranjeira et al. found that the majority of the 
neurons originated from progenitors that were present in the mid-gestational gut 
(2011). It was observed that enteric neural crest cells expressing Sox10 were 
highly neurogenic throughout embryogenesis, but neuronal differentiation ceased 
between postnatal months 1-3. The study demonstrated some level of 
neurogenesis in Sox10 mice, but only after BAC injury, and was not found in 
GFAP mice. Although Sox10 and GFAP are both markers for glia, the data 
suggests there may be a subpopulation of glia (GFAP-) that have neurogenic 
potential in vivo. Additionally, the neurogenic capabilities of glial cells were once 
again demonstrated in vitro as mature glial cells generated enteric neurons in 
culture. Despite these findings, neurogenesis was undetectable in vivo in the 
mature ENS.  
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SIGNALING PATHWAYS FOR NEURONAL PROLIFERATION 
RET and PTEN signaling are not restricted to the gut and are intimately involved 
in cell proliferation and survival. These known cellular and metabolic pathways 
may relate to the mechanism of neuronal turnover in the ENS, and thus recent 
studies have focused on particular receptor genes to further elucidate ENS 
neurogenesis. 
RET and EDNRB Signaling 
Diseases such as Hirschprung's have susceptible disease loci for established 
neurotrophic signaling receptors RET and EDNRB (Figure 4). Mutations of these 
genes lead to phenotypes like that of HSCR. Deletion of Ret in mice yields 
complete intestinal aganglionosis (Schuchardt et al., 1994), for instance, and 
enteric neurons in the gut are absent as a result of gene knock-down in zebrafish 
(Shepherd et al., 2004). Thus, RET and EDNRB ligand-receptor complexes are 
essential for ENS development, highlighted by equivalent aganglionosis 
phenotypes that arise in mice and zebrafish in the absence of Ret, Gdnf, or 
Gfrα1. 
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Figure 4: RET and EDNRB receptors are essential for ENS development. NCCs that infiltrate 
the gut express the RET receptor tyrosine kinase that is activated by dimerization following 
formation of a GDNF-GFRα1 dimer complex. Intracellular activated phosphotyrosines are shown 
above as small circles. As they migrate through the gut, NCCs also express G-protein-coupled 
receptor endothelin receptor B (EDNRB) that is activated by endothelin 3 (EDN3). [Adapted from 
Heanue & Pachnis, 2007] 
Ret and Gfrα1, the co-receptor to GDNF, are expressed by NCCs as they enter 
the gut tube. Gdnf, a neurotrophic factor derived from the glial cell line, is 
expressed in the gut mesoderm (Heanue & Pachnis, 2007). NCCs are able to 
migrate and survive without Ret activation prior to their arrival in the foregut, but 
Ret is necessary for NCC survival and migration through the gut. It is possible 
that RET belongs to a family of dependence receptors that stimulate cell death 
when there is no ligand activation (Durbec et al., 1996; Taraviras et al., 1999; 
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Bordeaux et al., 2000). Activation of the RET receptor occurs when its co-
receptor, GFRα1, binds its ligand, GDNF, and then dimerizes with RET.  
Mutations in GFRα1 or GDNF lead to intestinal aganglionsosis, and as 
demonstrated by in vitro studies, GDNF serves as a chemoattractive signal that 
attracts NCCs expressing Ret and Gfrα1 to their target region. Consequently, 
Gdnf is expressed in the stomach when NCCs are arriving at the developing 
esophagus, and is increased in the cecum as NCCs approach the distal gut 
(Young et al., 2001; Natarajan et al., 2002). The role of GDNF is underscored by 
the observation that Gdnf- mice had a roughly 50% reduction in enteric NCCs, 
likely a result of limited NCC proliferation and delayed migration in the gut 
(Gianino et al., 2003; Flynn et al., 2007). Heterozygous mutations in Gdnf have 
been identified in some human patients of HSCR, as well (Heanue & Pachnis, 
2007).  Therefore, these studies suggest that the GDNF-GFRα1-RET signaling 
pathway is crucial for NCC survival in the gut, as well as their ability to populate 
the GI tract.  
There are two main isoforms of RET, RET 9 and RET51, that differ in the 
intracellular carboxy C-terminus and the tyrosine sequence that serves as a 
docking site for both intracellular adaptor proteins and effector signaling 
molecules that activate mitogen-activated protein kinase (MAPK) and 
phosphatidylinositol 3-kinase (PI3K) (Takahashi 2001). Transgenic mice that only 
express the RET9 isoform exhibit complete gut colonization by enteric neurons 
(de Graaff et al., 2001), thereby demonstrating that RET9 is sufficient for GDNF-
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GFRα1-RET signaling without RET51 present. Consistent with this model, mice 
that expressed RET51 alone did not achieve enteric neuronal colonization in the 
distal colon (de Graaff et al., 2001). This particular pattern of colonization is 
similar to the aganglionosis found in HSCR patients and is believed to 
demonstrate an issue in NCC proliferation or migration (Natarajan et al., 2002). 
Other experiments, however, show that neither mice with only RET9 nor mice 
with only RET51 have overt phenotypes of the ENS (Jain et al., 2006), an 
inconsistency that may be the result of a difference in mouse strain that 
influences receptor signaling.  
Nonetheless, mutational analysis in mice has targeted potential signaling sites 
within RET to determine their necessity during ENS development. One such 
example is the Y1062 multi-docking site on RET9 that can be changed to a 
phenylalanine, which in mice leads to complete intestinal aganglionosis (Jain et 
al., 2006; Wong et al., 2005). This suggests that Y1062 is important for the 
development of the ENS. Mutations of other sites such as the PKA 
phosphorylation site of RET and extracellular cysteine residue 620 in mice have 
also been associated with a loss of neurons in the distal colon and total 
aganglionosis in the intestine, respectively (Carniti et al., 2006). The cysteine 
residue mutation specifically is one that is found in patients with HSCR (Plaza-
Menacho et al., 2006). However, it is important to note that genetic alterations do 
not necessarily yield the same ENS phenotypes between humans and mice; 
while heterozygous mutations in RET result in HSCR in humans, the subsequent 
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hypoganglionosis found in mice does not obviously affect gut function (Carniti et 
al., 2006). Nevertheless, models of colonic aganglionosis observed in mouse 
models with RET51 deficiency, for example, may represent a more suitable 
model for the investigation of human enteric disorders. 
Endothelin 3 (EDN3) and its G-protein-coupled receptor, EDNRB, are part of 
another signaling pathway that is essential for ENS development. Heterozygous 
mutations of these molecules, as well as an endothelin converting enzyme that 
converts the inactive precursor of EDN3 to its active state, have also been found 
in HSCR patients (Amiel & Lyonnet, 2001). Mice that have genetic mutations at 
these loci exhibit aganglionosis and pigmentation defects (Baynash et al., 1994; 
Hosoda et al., 1994; Yanagisawa et al., 1998). While Ednrb is expressed by 
NCCs migrating through the gut, Edn3 is expressed in the mesoderm of the mid- 
and hindgut during the initial phase of NCC migration. Additionally, Edn3 
expression is increased in the cecum and proximal colon when NCCs approach 
the terminal gut (Yanagisawa et al., 1998; Barlow et al., 2003). Therefore, much 
like the pattern of Ret expression, EDN3-EDNRB signaling is probably involved 
in coordinating the migration of NCCs through the gut. Studies have pinpointed 
the timeframe in which EDN3-EDNRB signaling is critical during NCC migration, 
specifically between days E10 and E12.5 (Shin et al., 1999). Additionally, enteric 
NCC numbers were found to be reduced in Edn3 mutant mice and NCC 
differentiation was halted as a result of EDN3; therefore it is possible that 
EDNRB maintains the proliferative state of enteric progenitors (Barlow et al., 
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2003). Evidently, both GDNF-GFRα1-RET and EDN3–EDNRB signaling 
pathways are crucial for ENS development. Interactions between the two 
pathways are a current matter of study, as the co-transmission of alleles for 
EDNRB and RET in HSCR patients may indicate some genetic association. 
The fine-tuned balance of genetic influence that determines the correct number 
of neurons and neuronal subtypes, as well as the size of the progenitor pool, can 
fluctuate dramatically in the gut. Regardless of the size of this pool, however, 
functional needs are still fulfilled. Therefore, the development of the ENS must be 
tied into the greater morphogenesis of the GI tract. This presents an avenue of 
research that is significant for unleashing the full potential of ENS neurogenesis 
in vivo—studying organogenesis of the gut may reveal the underlying 
mechanisms that determine the end-point of enteric plexus size. RET is merely 
one of many potential components that influence the organization of Peyer’s 
patches of the gut lymphoid system, for instance (Veiga-Fernandes et al., 2007). 
The natural patterns of migration in the gut provide an opportunity to unveil 
coordination of growth and proliferation as they pertain to steady-state 
neurogenesis. 
PTEN Signaling: ex vivo 
Although multipotent stem cells with the ability to differentiate into glia and 
neurons have been isolated from adult human and murine intestine, their function 
in ENS neurogenesis has been difficult to demonstrate in vivo. Studying ENS 
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neurogenesis ex vivo can be extremely valuable, however, as it may reveal 
mechanisms that can then be enhanced for in vivo study. 
Enteric neural stem cells have been isolated from various tissues, both 
embryonic and adult, with techniques that include growth selection and sorting by 
cell surface markers such as Ret, p75, CD49b, and fluorescent proteins. 
Properties of stemness and multipotency have been demonstrated in culture as 
well as the ability to colonize gut tissue ex vivo, influencing neuromuscular 
function (Bixby et al., 2002; Kruger et al., 2002; Lindley et al., 2008). However, in 
vivo observation is challenging, as demonstrated across many robust studies that 
have assessed numerous ENS injury models; neural plasticity has been found 
more than neurogenesis itself.  
With this in mind, Becker et al. chose to employ a novel approach to study 
neurogenesis by examining murine intestine in ex vivo organotypic culture. In 
order to better understand the processes behind neurogenesis, and perhaps 
what may be ‘holding it back’ in in vivo preparations, a phosphatase and tensin 
homolog on chromosome ten (PTEN) was assessed. PTEN is a lipid and protein 
phosphatase that regulates cell proliferation and survival, suppressing 
phosphatidylinositol-3-OH kinase (PI3K/Akt) signaling (Maehama et al., 1998; 
Stiles et al., 2004). It has also been suggested that PTEN maintains the 
quiescence of stem cells, and that deletions of PTEN causes increased 
proliferation of neural, hematopoietic, and embryonic stem cells as well as 
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hyperplasia of enteric ganglia (Puig et al., 2008).  This indicates that PTEN may 
have a similar role with eNCSCs.  
Becker et al. focused on PTEN mRNA expression, using the thymidine analog 
ethynyldeoxyuridine (EdU) to observe proliferation and neurogenesis in the ENS 
(2013). The group used mice in which Cre recombinase under the Wnt1 neural 
crest specific promotor drives tdTomato fluorescent protein (tdT) expression in 
cells that originated in the neural crest (WntI-cre;ldTomato). The small intestine 
was removed and the adherent myenteric plexus of the longitudinal muscle 
(LMMP) was isolated from underlying tissue and cultured in stem cell medium. 
There was significant EdU uptake into neurons and glia of the myenteric plexus 
by 48 hours after infusion of EdU in the ex vivo murine organotypic culture, thus 
allowing for observation of cell proliferation as it pertains to PTEN signaling. Cells 
of neural crest origin within the LMMP were visualized by tdT, and after 48 hours, 
78.5% of tdT-expressing cells demonstrated EdU uptake and proliferation was 
confined to cells of neural crest origin; in turn, 74.5% of EdU+ cells expressed 
tdT. In another experiment, PTEN was inhibited with potassium bisperoxo(1,10-
phenanthroline)oxovanadate [bpV(phen)], and a 3-fold increase in neuronal 
proliferation was observed in comparison to the control (Becker et al., 2013). This 
data establishes the proliferative capacity of neural crest cells in ex vivo 
conditions, and also highlights a dependency on PTEN to maintain neuronal 
progenitors in a quiescent state.  
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The model was then used to test small molecule inhibitors of PI3K in addition to 
PTEN—each of them greatly affected Akt-mediated proliferation and activity. 
Inhibition of PTEN augmented proliferation while a PI3K inhibitor blocked the 
transition from quiescence to proliferation. This indicated a PTEN/PI3K/Akt 
pathway in which decreased PTEN mRNA expression and increased inactivation 
of PTEN (via phosphorylation of the C-terminal tail) both increase Akt activity. 
Conversely, PI3K inhibition blocked said activity. This further emphasized PTEN 
dependency, a factor that has been found to affect proliferation and pluripotency 
in other tissues and cells such as embryonic and hemapoietic stem cells (Alva et 
al, 2011). Thus, PTEN signaling is likely to serve as the ‘natural brake’ that limits 
neurogenesis under steady-state conditions in vivo and subsequently may have 
intrinsic therapeutic benefit to restore bowel function through more extensive 
neurogenesis post-surgery. 
PTEN Signaling: in vitro and in vivo  
With the foundation that ex vivo study of neurogenic characteristics provides, in 
vitro and in vivo analysis can be performed. Due to the difficulty of proving adult 
enteric neurogenesis in vivo in comparison to the relative ease with which neural 
precursors can be isolated in vitro, researchers continue to seek the intrinsic 
mechanism which may exert a brake on ENS neurogenesis. Becker et al. and 
Kulkarni et al., among others, have been able to show a PTEN-mediated 
dampening of neurogenesis from neural crest cell-derived adult enteric neural 
precursors (ENPs) such as Nestin+ cells (2013; 2015). Kulkarni et al. 
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hypothesized that the ENP microenvironment and surrounding cellular matrix 
helps to support PTEN in an active state to regulate neurogenesis; 
understanding this potential mechanism would help explain why in vivo 
observations are so difficult to obtain.  
The longitudinal muscle-associated myenteric plexus (LMMP) of adult Wnt1-cre-
tdTomato mice, which would identify cells in the neural crest lineage, were 
cultured with EdU both with and without numerous components of the 
extracellular matrix (ECM) such as collagen and fibronectin. PTEN and p-PTEN 
(or phosphorylated, inactivated PTEN) levels were assessed between 
experimental groups. It was found that among all of the ECM proteins cultured 
with LMMP, Collagen IV (C-IV) was the only one to inhibit the proliferation of 
ENPs and was linked to a notable decrease in the ratio of p-PTEN to PTEN 
(Kulkarni et al., 2015). This in vitro experiment therefore demonstrates that the 
presence of C-IV, typically associated with the basal lamina, increases PTEN 
that in turn has been found to exert a brake on neurogenesis. 
In vivo experiments by Kulkarni et al. revealed that in knockout PTEN gut, total 
numbers of neurons and ganglia were substantially greater than in wild type. This 
further supports the role of PTEN as a limiter of neurogenesis: in its absence 
neuronal proliferation is markedly increased. Therefore, ENPs are shown to be 
capable of neurogenesis in vivo, regulated by PTEN signaling. If PTEN is absent 
or its regulation inhibited, neuronal proliferation would be more extensive. On the 
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other hand, if PTEN regulation is amplified in some way, such as in response to 
C-IV, fewer neurons and ganglia may arise and potentially indicate enteric 
disorders such as neuronal dysplasia of the intestine. Studies such as this 
continue to provide insight into novel directions for enteric therapeutics and begin 
to demonstrate in vivo data that affirms ENS neurogenesis.  
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5-HT4: SEROTONIN AS A NEUROGENIC AGONIST 
The full spectrum of stimuli and their effects on the ENS are unknown and 
perturbations of the GI tract have yielded inconsistent data in vivo. Neurogenesis 
has been demonstrated following chemical ablation of the myenteric plexus with 
benzalkonium chloride (BAC), but this has been contradicted with recent studies 
failing to detect neurogenesis despite the induction of numerous injuries to the 
gut (Joseph et al, 2011). eNCSCs persist in adult mouse and human intestine, 
but research has not demonstrated with replicable results that they give rise to 
new neurons under steady-state conditions in vivo in order to compensate for 
those that are injured or lost (Belkind-Gerson et al., 2013).  
Although enteric neuronal stem cells have been found in the postnatal murine 
bowel in several studies and would appear to be a potential source of new 
neurons, single pulses of BrdU have not successfully demonstrated the 
emergence of neurons beyond the first few postnatal months in the adult ENS 
(Bixby et al., 2002; Kruger et al., 2002; Heanue & Pachnis, 2007). Similarly, 
constitutive neurogenesis in rodents continues during early postnatal life but then 
ceases (Pham et al., 1991).  While the cellular origin of newly born enteric 
neurons remains unclear, recent evidence suggests that the cells arise from 
enteric glia (Laranjeira et al., 2011). The capabilities of the enteric glial cell are 
thus a new focus of gastroenterological research, which follows similar data 
pertaining to the neurogenic potential of radial glia in the CNS (Merkle et al., 
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2004; Tramontin et al., 2003). Both the glial cells and the neurogenic process 
overall can be influenced by serotonin, a powerful molecular tool for 
neurogenesis research. 
The bowel contains a surprisingly high concentration of serotonin, or 5-
hydroxytryptamine 4 (5-HT4) (Erspamer, 1966). Many receptor subtypes are 
expressed in the ENS and regulate motility and secretion, which links 5-HT4 to 
the pathophysiology of gastrointestinal disorders such as IBS and chronic 
constipation (CC) (Galligan & Parkman, 2007). CC in particular is associated with 
age-related neuronal decline, and thus the ramifications of 5-HT4 as an agonist of 
neurogenesis include improved efficacy of treatment for GI disorders (Camilleri et 
al., 2008). These have been shown to resolve with 5-HT4 agonist treatment 
(Gershon & Tack, 2007). 5-HT4 functions by presynaptically enhancing secretion 
of acetylcholine and calcitonin gene-related peptide (CGRP), increasing the 
amplitude of enteric progenitors and strengthening prokinetic neurotransmission 
(Liu et al., 2009). 5-HT4 binds to abundant receptors that arise early in fetal life 
(Gershon & Ratcliffe, 2006). The exact mechanism by which it mediates 
neurogenesis following injury is unknown, but it is an increasingly active area of 
research.  
5-HT4 Receptor Function 
Studies under steady-state conditions, without injury or added reagents, have 
yielded limited evidence of ENS neurogenesis. However, great strides have been 
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made to unlock the mechanisms that may regulate steady-state neuronal 
proliferation by assessing agonists that may promote neurogenesis. Liu et al. 
was able to study 5-HT4 under both in vitro and in vivo conditions (2009). 
Comparing wild type (WT) and knock-out (KO) mice that lacked 5-HT4 receptors, 
the number of enteric neurons were similar at birth, but only increased during the 
first 4 months after birth in WT mice. Affirming a well-established phenomenon of 
ceased neurogenesis in mature gut, Liu et al. found that the enteric neurons then 
decreased in both WT and KO mice; however, after 12 months, WT mice were 
left with more enteric neurons than KO mice. This is consistent with the notion 
that 5-HT4 receptors mediate neuronal proliferation in the gut. 
After testing the effects of the absence of 5-HT4 receptors, Liu et al. stimulated 
the receptor to assess the promotion of enteric neuron survival and 
neurogenesis. In vitro, 5-HT4 agonists increased neuronal survival and 
development as well as cellular metabolic activity by activating CREB (cAMP 
response element-binding protein). Additionally, apoptosis was analyzed by 
observing the survival of enteric neurons through DNA staining and TUNEL 
assays, and it was found that 5-HT4 agonists decreased neuronal apoptosis. In 
vivo, it was determined that 5-HT4 agonists in WT mice induced BrdU 
incorporation in cells that expressed the neuronal markers HuC/D and double 
cortin, the neural precursors Sox10, Nestin, and Phox2b, and stem cells via 
Musashi-1. BrdU infusion, as previously described, is a method of observing 
neurogenesis and is depicted in Figures 5 and 6. This did not occur in KO mice; 
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the number and size of the myenteric neurons decreased as a function of age in 
KO mice as was determined by comparing myenteric neuronal density. Effects to 
the ENS in the KO mice manifested as delayed gastric emptying and slow small 
intestine transit time (Liu et al, 2009). This study was an early affirmation that 5-
HT4 receptors are required postnatally for ENS growth and maintenance, as well 
as a potential model for GI disorders due to the perturbations of the gut in KO 
mice. 
 
Figure 5: Immunofluorescent imaging of BrdU uptake and S100β glial cell labeling. (B) 
BrdU-labeled nuclei from the myenteric ganglia (indicated by the arrow and arrowhead). (D) 
S100β immunoreactivity marking the enteric glial cells, with the arrow and arrowhead pointing to 
nucei that incorporated BrdU. [Adapted from Liu et al., 2009] 
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Figure 6: Cells displaying 5-HT4- induced BrdU incorporation, expressing markers 
associated with neural crest-derived progenitors. 4 weeks after BrdU infusion, BrdU is 
incorporated into extraganglionic Hu-immunoreactive cells labeled for Sox10 Phox2b (E1 with 
arrow, E2). The position of mature neurons within the myenteric ganglia is indicated by HuC/D 
immunoreactivity. Panel E2 is an example of a typical myenteric ganglion with Hu and Phox2b, 
myenteric neurons, Sox10, and enteric glia. Panel F includes arrows that indicate nuclear uptake 
of BrdU. Panel G shows cells that incorporated BrdU in a WT mouse treated with RS67506 (an 
agonist of the 5-HT4 receptor). [Adapted from Liu et al., 2009] 
Inducible Models: Anastomosis and Colitis 
Another group explored 5-HT4 agonists in vivo in a novel application of 
reconstructing the circuitry that mediates a distal gut reflex. The 5-HT4 agonist 
mosapride citrate (MOS) was applied to guinea pig and rat models that 
underwent rectal transection and anastomosis. Takaki et al. sought to determine 
regenerative activity in the impaired neural circuit and subsequently the distal gut 
reflex (2014). Once again, neural growth in the granulation tissue was observed 
with positive identification of 5-HT4 receptor- and BrdU-expressing cells; 
application of an antagonist yielded no positive cells. This research encouraged 
the combined utilization of injury models and 5-HT4 agonists in the context of 
ENS neurogenesis, and results began to suggest an amplification of the 
neurogenesis already induced in a standard injury model. 
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An alternative directly inducible injury that can be used to study 5-HT4 agonism is 
inflammation, or colitis. Past studies have shown that in cases of inflammatory 
bowel disease, enteric neuronal hyperplasia is observed, which further suggests 
that new neurons can be found in mature gut (Geboes et al., 1998; Lakhan et al., 
2010). Thus, based on the evidence of serotonin agonism in the postnatal gut 
and this observation of enteric hyperplasia, Belkind-Gerson et al. hypothesized 
that colitis might induce a strong neurogenic response dependent on the 5-HT4 
receptor (2015).  
Again, 5-HT4 agonism and antagonism were both assessed in vitro and in vivo. 
In vitro, agonism of 5-HT4 led to increased neuronal density as seen in Figure 7, 
but interestingly induction of colitis by application of 3% dextran sulfate sodium 
(DSS) in vivo resulted in glial cell proliferation that did not increase glial cell 
numbers. This suggests that glia may actually have a primary role in 
neurogenesis rather than a merely supportive role, underscored by the 
observation that a neuronal network arose from isolated glia that were 
transplanted into aganglionic avian hindgut as demonstrated in similar studies in 
the past. Additionally, immunoselected enteric glia gave rise to neurons in 
culture, an effect that was nullified in a 5-HT4 blockade (Belkind-Gerson et al., 
2015). Induction of colitis in normal transgenic mice with Nestin-GFP and Sox2-
GFP demonstrated that those glial markers (Sox2, Nestin, and CD49b) were 
strongly expressed by neurons, providing early evidence that glial cells may 
transdifferentiate into neurons. This is represents a significant shift in dogma, as 
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glia have been assumed to de-differentiate into progenitors and then differentiate 
into neurons. Therefore, the notion that glial cells may transdifferentiate into 
neurons is a novel proposal. 
Figure 7: 5-HT4 enhances enteric neurogenesis in vitro. Dissociated enteric neuronal stem 
cells were cultured in control media (panels A and D) or in the presence of 100 nM RS67506 
(RS), a 5-HT4 receptor agonist (panels B and E). The arrow in panel E, also enlarged in the inset, 
designates a proliferating neuron. Addition of RS to the cultures increased the density of neurons; 
however, the density of glial cells did not increase (plot C). RS led to a significant increase in the 
rate of both neuronal (Tuj1) and glial cell (GFAP) proliferation (plot F). It is important to note that 
the 5-HT4 itself did not make the colitis worse; colitis was induced by adding 3% dextran sulfate 
sodium (DSS). [Adapted from Belkind-Gerson et al., 2015] 
This strong in vitro and in vivo evidence for a 5-HT4-dependent neurogenic 
mechanism revealed an unexpected pattern of glial cell proliferation: in the 
setting of colitis, glial cell proliferation increased dramatically, yet glial cell 
numbers remained the same. Concurrently, neuron numbers increased, and 
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there was evidence that these neurons were derived from glia in mechanism 
mediated by 5-HT4. Signaling pathways such as 5-HT4, particularly in the context 
of induced injury or inflammation, may be critical to the underlying mechanism of 
enteric neurogenesis. Furthermore, the fundamental role of glial cells, a cell type 
classically understood to be neuronal support cells providing nourishment and 
maintenance to the surrounding environment, is emphasized by their potential 
ability to transdifferentiate directly into neurons. 
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TEMPORAL INFLUENCE ON GASTROINTESINAL NEURAL POPULATION 
Proliferative signals are constantly changing in the gut, and these can affect 
enteric neurogenesis. Investigated pathways such as the RET/GDNF/GFRα1 
signaling pathway, for example, may control cell proliferation during the migration 
of NCCs but may not necessarily regulate proliferation beyond the migratory 
phase (Chalazonitis et al., 1998). However, temporal regulation of the ENS 
pertains to more than growth factors and G-proteins, as the microbiota of the gut 
elicits major changes to patterns of enteric proliferation as well. 
Gut Microbiota: Enteric Gliogenesis 
Although neurogenesis is as of yet difficult to observe on a large scale in vivo, it 
is not unrelated to the development, organization, and function of the enteric glial 
cells. Ablation of these cells, as can be observed in genetically modified animals 
or via experimental application, demonstrates their role in neuronal maintenance. 
When enteric glia are removed, neuronal degeneration results and neuronal 
function is impaired (Bush et al., 1998; Nasser et al., 2006). Therefore, it is 
postulated that enteric glia regulate extracellular homeostasis as well as 
substrate supply (Cabarrocas et al., 2003). As more is being learned about the 
role of glial cells in the ENS, additional information may be revealed about the 
neurons themselves. Kabourdis et al. demonstrated that the network of mucosal 
glial cells in the ENS continues to develop after birth and is a constantly renewed 
homeostatic cell population influenced by gut microbiota (2015).  
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The mucosal glial cells of the ENS are known to maintain the epithelial barrier 
within the intestine and to regulate the gastrointestinal immune response, as well 
as nourish neurons and regulate synaptic transmission (Clarke & Barres, 2013; 
Alvarez et al., 2013). These responsibilities are intertwined with developmental 
and degenerative disorders that can affect the ENS (Skaper et al., 2014). Unlike 
enteric neurogenesis, low levels of gliogenesis are ongoing in the adult rodent 
gut, although the endpoint of newly generated glial cell migration and function is 
yet unknown (Joseph et al, 2011). Enteric glial cells (ECGs) have varying 
subtypes with different roles in intestinal homeostasis, but it is unclear as to the 
signaling between ECGs to maintain homeostatic equilibrium and the response 
of glial cells to trauma (Boesmans et al., 2015; Gulbransen & Sharkey, 2012).  
Mucosal EGCs specifically, or mEGCs, have sparked interest as they are 
neuroprotective in nature and reside in the most dynamic layer of the gut (Ruhl et 
al., 2004); hence researchers such as Kabourdis et al. have sought to define the 
relationship between these mEGCs and the surrounding microbiota as well as 
their maintenance of the mucosal immune system. According to lineage tracing 
analysis, the network of mEGCS is maintained throughout life due to a 
continuous supply of new glial cells that come from peripheral plexuses. 
Additionally, antibiotic treatment in mice revealed that both the mEGCS within the 
mucosa and the glial cells of the lamina propria are regulated by the gut 
microbiota (Kabourdis et al., 2015). Therefore, changes in the microbiota are also 
reflected in the neurons due to their dependence on the glial cell population. 
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Postnatal mEGC Network 
The first step in establishing a connection between gut microbiota and neuronal 
homeostasis within the gut wall begins with the discovery that the network of 
mEGCs develops postnatally. This was achieved by immunostaining sections of 
adult murine intestine for the glia-specific marker S100β, revealing a complex 
network of EGCs that span the MP and SMP to the lamina propria, between the 
crypts and within the villi themselves (Kabourdis et al., 2015). Morphology was 
determined by combining the Sox10::Cre driver, which stimulates biased 
inheritance of the gene, with MADM alleles to express green fluorescent protein 
(GFP) in subsets of peripheral glial cells (Matsuoka et al., 2005; Zong et al., 
2005; Boesmans et al., 2015). Within these subsets, the mEGCS were highly 
branched, making contact with mucosal tissues such as the epithelium, blood 
vessels, and neurites (Bohórquez et al., 2014; Liu et al., 2013). In order to 
determine the timeline of development, Kabourdis et al. immunostained intestinal 
segments of Sox10::Cre;R26REYFP reporter mice at different stages before and 
after birth in combination with S100β and YFP antibodies as well as a neuronal 
marker. As a result, it was found that about half of the villi at the embryonic stage 
E16.5 contained neuronal fibers protruding from the enteric ganglia and most villi 
had these protrusions at postnatal day P0. However, the lamina propria did not 
contain any glial cells at both of these time points, demonstrating a postnatal time 
course for much of the glial cell population; a full adult complement was not 
reached until P27 (Figure 8).  
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Figure 8: mEGC network develops postnatally. Establishing a postnatal timeline for the 
development of mEGCs allows for further analysis of the effects of the microbiome as well as 
gliogenesis in the ENS. (A) S100β immunostaining of a cross-section of ileum in a wild-type 
mouse with MP and SMP included. EGCs are indicated by white arrows in the lamina propria 
within villi and surrounding the crypts. (B) In Sox10::Cre;MADMGR/RG mice, the extensive 
branching of GFP+ glial cells is shown in the mucosa of the ileum (white arrows). (C) S100β 
immunostained cryosection of mucosa in P0 mouse; (D) P10 mouse; (E) adult mouse. Arrows 
point to the mEGCs. [Adapted from Kabourdis et al., 2015] 
Additionally, weaning of the mice was correlated with expansion of mEGCs after 
P10 when these experiments were repeated with pre-weaning and post-weaning 
groups. Weaning is associated with a change in the microbiome, causing major 
changes to the macronutrients in the intestinal lumen and altering the intestinal 
epithelium (Henning, 1981). Thus, initial data suggested a response by the 
mEGC network to the exposure of the GI tract to postnatal nutritional demands 
and the novel luminal environment. 
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With such a highly regenerative epithelium as that of the intestine, the turnover of 
mEGCs in the lamina propria must also be considered. Due to mechanical 
activity, the intestinal epithelium itself is completely renewed every few days 
(Creamer et al., 1961). Because ganglionic EGCs can respond to injury and 
inflammation, gliogenesis within the adult ENS is upregulated to maintain the glial 
cell population (Joseph et al., 2011; Laranjeira et al., 2011). In order to identify 
the source of mEGCs when the glial cells are renewed, as well as the pattern of 
mEGC turnover, an inducible Cre recombinase driven by the Sox10 promoter 
(Sox10::CreERT2) was used to trigger Confetti (R26R-Confetti) reporter 
expression in vivo (Kabourdis et al., 2015). Confetti is a multicolor reporter that, 
in R26R-Confetti mice, delineates each individual cell lineage by the expression 
of a random combination of one of four fluorescent proteins that were observed 
four days after the Confetti reporter was induced (2015). While mEGCs located in 
the lamina propria were mostly unlabeled, those that were labeled in the lamina 
propria were few and far between—individual, monochromatic glial cells. 
However, 15 days after induction, 72% of the villi had labeled, polychromatic 
mEGCs within the lamina propria including clusters in the villi cores (Kabourdis et 
al., 2015). This data implies a relationship between cells with Sox10 expression 
and mEGCS, and it is possible that the Sox10-expressing cells give rise to new 
mEGCs within the mature myenteric plexus that then travel to the mucosa.  
In order to solidify the proposed direction of migration for new mEGCs, lineage 
tracing of the cells was analyzed for expression of a second glial marker, GFAP 
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(or glial fibrillary acidic protein). Results demonstrated that, in murine adult 
intestine, new mEGCs appeared in the lamina propria 8-12 weeks after the 
fluorescent reporter was induced. This suggests that new mEGCs in mice arise 
from cells that express Sox10 and GFAP within the enteric glia and then migrate 
from peripheral ganglia to repopulate the lamina propria in what can be 
generalized as a centripetal flow (Kabourdis et al., 2015).  
Diet, Environmental Factors, and Gut Flora 
With the direction of new mEGC origin further explained, the impact of microbiota 
on already mature mEGCs can be assessed. mEGC development is tied to the 
colonization of the intestinal microbiome as suggested by the weaning/pre-
weaning phase of experimentation, but Kabourdis et al. took their analysis a step 
further by assessing mEGCs from animals housed conventionally versus raised 
in a germ-free environment. It was found that the number of mEGCs was 
drastically reduced in the germ-free mice, with no mEGCs in the villus cores and 
scant mEGCs in the lamina propria at crypt level. Moreover, once the normal gut 
microbiota was restored in these mice, the deficiency was reversed. 
The same pattern was encountered when Kabourdis et al. analyzed 8- to 12-
week-old mice treated with antibiotics as displayed in Figure 9 (2015). After 3 
weeks, the ileum was immunostained with S100β to reveal that antibiotic 
treatment reduced the number of S100β+ glial cells within the mucosa paired with 
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a reduction in gut micro-organisms and an enlargement of the cecum. mEGCs 
within the villi were most affected in comparison to around the crypts.  
 
Figure 9: The effect of antibiotics on the number of glial cells. On average, the number of 
Confetti+ cells in the villus-crypt units is reduced in mice treated with antibiotics. Data shown is 
the mean ± the standard error of the mean. [Adapted from Kabourdis et al., 2015] 
In the interest of further examining whether the antibiotics disrupted the 
homeostasis of EGC flow along the plexus-crypt-villus axis, Confetti lineage 
tracing was repeated. Glial populations that were administered antibiotics 
suffered a dramatic reduction in the polychromatic mEGC population over two 
weeks, and thus both of these antibiotics experiments support the notion that 
signals from the gut microbiota may both initiate and maintain centripetal flow of 
the new mEGCs that repopulate the lamina propria (Kabourdis et al., 2015). With 
each alteration to the microbiota of the GI tract, direct effects were observed in 
both the neurons and glial cells—a relationship that is a strong trend across 
multiple studies. The centripetal migration of cells from the peripheral ganglia 
inward is further corroborated by the recent study of Schwann cell progenitors 
and extrinsic innervation. 
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NOVEL CELLULAR ORIGINS FOR ENTERIC NEURONS 
It is evident that neurogenesis in the ENS occurs postnatally, starting during mid-
gestation, and lineage tracing data affirms that neural crest cells originate at 
vagal and sacral levels during development (Le Douarin & Teillet, 1973; Le 
Douarin & Kalcheim, 1999). The neural crest cells invade the gut wall to become 
enteric NCCs, and after travelling along the gut wall become integrated into the 
full length of the GI tract (Obermayr et al., 2013). Due to the relatively long time 
period in which neurogenesis can occur, neurogenic potential within the neural 
progenitors must be maintained—a unique characteristic of the ENS in 
comparison to the rest of the peripheral nervous system. The ENS has a basic 
ganglion structure that is developed via intrinsic innervation with enteric NCC-
derived neurons, but later in development the ENS also has substantial extrinsic 
innervation in which Schwann cell progenitors (SCPs) invade the gut wall 
alongside extrinsic nerve fibers (Figure 10).  
Schwann Cell Progenitors: Extrinsic Innervation  
The significance of SCPs in neural development was affirmed by a recent study 
that genetically traced developing mouse embryos in mid-gestation. The study 
showed that cranial nerve-associated neural progenitor cells of the 
parasympathetic ganglia express markers for SCPs, and another study 
demonstrated the NCC-like multipotency of adult sciatic nerve-associated 
Schwann cells with the ability to differentiate into neurons, glia, and smooth 
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muscle in culture (Dyachuk et al., 2014; Espinosa-Medina et al., 2014; Widera et 
al., 2011). These experiments revealed that SCPs are critical to neuronal growth 
beyond the early developmental stages and that the SCP differentiation into 
neuronal cell populations may be a more general pattern found throughout the 
body. This prompted researchers Uesaka et al. to further investigate SCP-
derived neurogenesis in vivo in the context of the ENS.  
 
Figure 10: Schematic diagrams illustrating the extrinsic innervation of the stomach and GI 
tract. In the left panel, the location of extrinsic nerve fibers is detailed in blue and intrinsic 
innervation is shown in green. In the right panel, a magnified cross-sectional view is shown, 
depicting the projection of extrinsic nerve fibers into the gut at embryological day E14.5. [Adapted 
from Uesaka et al., 2015] 
Uesaka et al. utilized genetic fate mapping to support the notion that SCPs have 
neurogenic potential and are an active part of postnatal neurogenesis in the 
ENS. SCP-derived neurogenesis was found in the absence of vagal neural crest-
derived ENS precursors in the submucosa of the small intestine. As the enteric 
NCCs rely on GDNF signaling via the RET/GFRα1 receptor complex for 
proliferation, mice that are Gdnf, Ret, or Gfrα1 deficient lack all enteric NCC-
derived intrinsic innervation in the intestines (Durbec et al., 1996). However, 
Uesaka et al. carefully examined the small intestine of Ret- or Gfrα1-deficient 
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embryos and found that there were some neurons around the time of birth. 
These neurons were found only in the submucosa, associated exclusively with 
extrinsic innervation; while it is difficult to characterize the GI tract in its entirety, 
Ueseka et al. found that there were no neurons detected in areas with scant or 
absent extrinsic innervation. These genetically deficient embryos produced 
aganglionic gut segments due to the lack of enteric NCC-derived intrinsic 
innervation, and therefore the submucosal regions with some neurons were 
interrupted by aganglionic segments primarily located far from the stomach. 
Enteric NCCs appear to stop migrating and die in the rostral part of the foregut 
when Ret signaling is absent, suggesting that it is unlikely any neurons found in 
the small intestine of Ret- or Gfralpha1-deficient embryos are derived from 
enteric NCCs (Taraviras et al., 1999). Admittedly, the data is not robust, but 
collectively the data supports the concept that neurogenesis can still occur 
without enteric NCCs due to the extrinsic innervation of the gut. 
Due to the invasion of Ret-deficient small intestine around mid-gestation, or 
E13.5, SCPs were also genetically traced using the Dhh-Cre driver; Dhh is a 
gene expressed in SCPs and Schwann cells that controls formation of the 
connective tissue sheath surrounding peripheral nerves (Jaegle et al., 2003; 
Bitgood & McMahon, 1995; Parmantier et al., 1999). Gfrα1 is usually expressed 
in both SCPs and enteric NCCs, but in the compound animal GFP reporter 
expression was found only in the SCPs. This confirmed that SCPs could be 
labeled specifically with Dhh::Cre, and thus mice deficient in Gfrα1 but harboring 
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a Dhh::Cre transgene as well as the Retfl-CFP reporter allele could be examined. 
It was found that all submucosal neurons in the Gfrα1-deficient small intestine 
expressed CFP (another fluorescent protein; Uesaka et al., 2015), further 
affirming that neurons in enteric NCC-free intestine may be derived from SCPs 
that populate the gut via extrinsic innervation.  
With these advances, SCP-derived neurogenesis was analyzed in the presence 
of enteric NCCs, in fully innervated small and large intestines. All GFP+ cells 
expressed glial cell markers but did not express progenitor/neuronal markers. In 
the small intestine, SCPs were extremely scant in the myenteric plexus. In 
contrast, at E14.5 in the large intestine SCPs were found along the extrinsic 
nerve but not in the mesenchyme. By E16.5, the first wave of SCPs had invaded 
the gut mesenchyme. Following the fate of the SCPs, Uesaka et al. found that 
the SPCs eventually populated both the myenteric and submucosal layers in the 
large intestine, and that PGP9.5+ neurons emerged in a subset of GFP+ cells 
postnatally at one month (2015). This suggests that SCP-derived neurogenesis 
indeed occurs in the gut, which is normally populated by enteric NCCs. Uesaka 
et al. was also able to demonstrate neurogenesis in vitro by plating embryos and 
growing the cells in culture, finding that the GFP-labeled SCPs acquired neuronal 
identity by day 10 in culture. Therefore, a degree of SCP-derived neurons were 
achieved both in vivo and in vitro. 
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This discovery is critical, as SCP-derived neurons were found make up a 
noteworthy population of the ENS—up to 20% of enteric neurons in the large 
intestine under physiological conditions—the majority of which differentiate into a 
particular, restricted neuronal subtype that expresses calretinin. Furthermore, 
Uesaka et al. reverse-engineered the contribution of SCPs to the neuronal 
population of the gut by inactivating the signaling receptor, RET, in SCPs (2015). 
The number of enteric neurons in the distal colon was reduced, leading to colonic 
oligoganglionosis; this demonstrates that SCP-derived neurons are indeed a 
fundamental part of ENS structure. The relatively substantial SCP-derived 
population in the ENS introduces a new question as to whether the SCPs are 
truly distinct from the sacral enteric NCC population. 
Peripheral glial cells influencing neuronal differentiation may explain some of this 
phenomenon, as satellite glia in immature developing ganglia can become 
neurogenic when challenged in an ectopic environment (Ayer-LeLievre & Le 
Douarin, 1982). However, these cells express autonomic ganglion progenitors 
and are therefore not committed to the Schwann cell lineage. Consequently, this 
does not confirm whether cells that are already terminally committed to Schwann 
cell lineage can differentiate into neurons (Young et al., 2003), but the study from 
Uesaka et al. demonstrates that committed SCPs retain neurogenic potential and 
ultimately differentiate into neurons. The capacity for cross-lineage differentiation 
is significant because the long-term maintenance of SCP-derived neurogenesis 
in the ENS enables researchers to understand pathologies of the ENS and 
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peripheral nervous system as a whole, expanding the potential for biomedical 
therapeutics and tissue engineering. 
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CONCLUSION & FUTURE DIRECTIONS 
Contrary to long held dogma, we now know that neurogenesis does occur in the 
brain. The central nervous system is explored as a potential analogue to the 
ENS, even serving as a control tissue for investigations into ENS neurogenesis 
(Joseph et al., 2011). The neurogenic pattern that has been supported across 
many studies reveals a continued emergence of neurons beyond embryogenesis 
and into the postnatal period, but direct observation of this phenomenon in vivo is 
limited. While this may seem to be a significant hindrance as researchers strive 
to achieve replicable results, the limitations of steady-state results actually mirror 
natural checkpoints built into the gut in order to regulate neuronal growth such as 
via the PTEN signaling pathway. This is a crucial preventative function that has 
made in vivo neurogenesis seem elusive, as the gut must protect itself from both 
extremes of neurogastrointestinal pathology—hypo-ganglionosis and 
hyperplasia.  
Early applications of direct bowel injury yielded inconsistent results, however the 
eventual combination of inducible injury and genetic models with receptor 
agonism uncovered both distinct ENS responses and novel cellular origins. For 
instance, the coupling of 5-HT4 receptor agonism with colitis produced strong in 
vitro and in vivo evidence that glial cells likely transdifferentiate into neurons 
(Belkind-Gerson et al., 2015). 5-HT4 agonism was even paired with surgical 
anastomosis to demonstrate restoration of a distal gut reflex (Takaki et al, 2014). 
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Moreover, the application of Ret-deficient embryos was paired with genetic fate 
mapping of Schwann cell progenitors  to determine whether neurogenesis might 
still occur without enteric NCCs. Researchers were able to make powerful 
revelations by a) creating the need for restoration of injured enteric neurons via 
an inducible insult to the gut, b) utilizing a well-established agonist or signaling 
pathway to amplify  baseline neurogenic cell turnover, and c) focusing on not 
only neural crest cells and enteric stem cells but subtypes such as enteric glial 
cells and Schwann cell progenitors that may invade the gut to contribute to the 
emergence of new neurons. 
In order for therapeutics to advance beyond surgical intervention, future work will 
be needed to determine, for example, which minute changes within the gut 
encourage uncommitted enteric neural crest-derived cells to differentiate into 
neurons, glia, or other cell types associated with that particular change in 
microenvironment. Disorders of the gut directly affect the luminal environment, 
and therefore it must be determined whether the microbiome in fact alters mEGC 
migration and subsequently differentiation, or if gut flora is primarily interacting 
with other cellular components or extracellular structures. Additional studies are 
needed to characterize the spectrum of stimuli that evoke a neurogenic response 
in the ENS and the pathways that regulate it. 
There are inherent difficulties with in vitro studies as well, as cultured cells are 
removed from the in vivo environment and are potentially disrupted. This 
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disruption may become critical to future studies that depend heavily on in vitro 
data to confirm in vivo observations, and thus there is an experimental and 
therapeutic advantage to the creation of subject- or patient-specific induced 
pluripotent stem cell or neural crest-like cells that would be less affected by 
isolation from enteric stem cells. This would allow for greater ease of study, 
especially for further analysis of RET, PTEN, and Sox10 signaling. 
Indeed, the ultimate goal is to observe ENS neurogenesis, with replicable and 
corroborative results, as it occurs under steady-state conditions. However, 
uncovering the mechanism behind the birth of new neurons does not rely on 
steady-state observation alone, as inducible injury and genetic models can 
stimulate the ENS to its maximum level of productivity and characterize disease 
states that are indicated by aggressive dysfunction and disrepair. The studies 
assessed in this report, and the induction of neurogenesis via injury, reflects the 
disease states they aim to resolve. The mechanism of ENS neurogenesis may in 
turn shed light on the solution for neurological disorders of the CNS, potentially 
enhancing the development of therapeutics for both mind and body. 
 
 
  
 59 
REFERENCES 
Altman, J. (1969). Autoradiographic and histological studies of postnatal
 neurogenesis. IV. Cell proliferation and migration in the anterior forebrain,
 with special reference to persisting neurogenesis in the olfactory bulb.
 Comparative Neurology, 137(4), 433-457. 
Alva, J. A., Lee, G. E., Escobar, E. E. & Pyle, A. D. (2011). Phosphatase and
 tensin homolog regulates the pluripotent state and lineage fate choice in
 human embryonic stem cells. Stem Cells, 29, 1952–1962. 
  
Alvarez, J. I., Katayama, T. & Prat, A. (2013). Glial influence on the blood brain
 barrier. Glia, 61, 1939–1958. 
 
Amiel, J. & Lyonnet, S. (2001). Hirschsprung disease, associated syndromes,
 and genetics: a review. Journal of Medical Genetics, 38, 729–739. 
  
Anderson, R. B., Stewart, A. L. & Young, H. M. (2006). Phenotypes of neural
 crest-derived cells in vagal and sacral pathways. Cell Tissue Research,
 323(1), 11-25. 
   
Ayer-Le Lievre, C.S. & Le Douarin, N.M. (1982). The early development of 
 cranial sensory ganglia and the potentialities of their component cells
 studied in quail-chick chimeras. Developmental Biology, 94, 291-310.  
  
Baetge, G. & Gershon, M. D. (1989). Transient catecholaminergic (TC) cells in
 the vagus nerves and bowel of fetal mice: relationship to the development
 of enteric neurons. Develpmental Biology, 132, 189-211. 
  
Balemba, O. B., Hay-Schmidt, A., Assey, R. J., Kahwa, C. K., Semuguruka, W.
 D. & Dantzer V. (2002). An immunohistochemical study of the organization
 of ganglia and nerve fibers in the mucosa of the porcine intestine.
 Anatomia, Histologia, Embryologia, 31, 237-246. 
 
Barlow, A., de Graaff, E. & Pachnis, V. (2003). Enteric nervous system
 progenitors are coordinately controlled by the G protein-coupled receptor
 EDNRB and the receptor tyrosine kinase RET. Neuron, 40, 905–916. 
 
Batchelor, P. E., Liberatore, G. T., Porritt, M. J., Donnan, G. A. & Howells, D. W.
 (2000). Inhibition of brain-derived neurotrophic factor and glial cell line
 derived neurotrophic factor expression reduces dopaminergic sprouting in
 the injured striatum. European Journal of Neuroscience, 12, 3462-3468. 
 
 60 
Baynash, A. G., Hosoda, K., Giaid, A., Richardson, J. A., Emoto, N., Hammer, R.
 E. & Yanagisawa, M. (1994). Interaction of endothelin-3 with endothelin-B
 receptor is essential for development of epidermal melanocytes and
 enteric neurons. Cell, 79, 1277–1285. 
  
Becker, L., Peterson, J., Kulkarni, S. & Pasricha, P. J. (2013). Ex Vivo
 Neurogenesis within Enteric Ganglia Occurs in a PTEN Dependent
 Manner. PLoS ONE, 8(3), e59452. 
  
Belkind-Gerson, J., Carreon-Rodriguez, A., Benedict, L. A., Steiger, C., Pieretti,
 A., Nagy, N., … Goldstein, A. M. (2013). Nestin expressing cells in the gut
 give rise to enteric neurons and glial cells. Neurogastroenterology &
 Motility, 25(1), 61-69. 
  
Belkind-Gerson, J., Hotta, R., Nagy, N., Thomas, A. R., Graham H., Cheng, L.,
 … Goldstein, A. M. (2015). Colitis induces enteric neurogenesis through a
 5-HT4-dependent mechanism. Inflammatory Bowel Diseases. 0, 1-9. 
  
Bitgood, M.J. & McMahon, A.P. (1995). Hedgehog and Bmp genes are
 coexpressed at many diverse sites of cell-cell interaction in the mouse
 embryo. Developmental Biology, 172, 126-138.  
  
Bixby, S., Kruger, G. M., Mosher, J. T., Joseph, N. M. & Morrison, S. J. (2002).
 Cell-intrinsic differences between stem cells from different regions of the
 peripheral nervous system regulate the generation of neural diversity.
 Neuron, 35, 643–656. 
  
Bjerknes, M. & Cheng, H. (2001). Modulation of specific intestinal epithelial
 progenitors by enteric neurons. Proceedings of the National Academy of
 Sciences, 98, 12497-12502. 
  
Boesmans, W., Lasrado, R., Vanden-Berghe, P. & Pachnis, V. (2015).
 Heterogeneity and phenotypic plasticity of glial cells in the mammalian
 enteric nervous system. Glia, 63, 229–241. 
  
Bohorquez, D. V., Samsa, L. A., Roholt, A., Medicetty, S., Chandra, R., & Liddle,
 R. A. (2014). An enteroendocrine cell-enteric glia connection revealed by
 3D electron microscopy. PLoS ONE, 9(2), e89881. 
  
Bordeaux, M. C., Forcet, C., Granger, L., Corset, V., Bidaud, C., Billaud, M., …
 Mehlen, P. l., 2000. The RET proto-oncogene induces apoptosis: a novel
 mechanism for Hirschsprung disease. EMBO, 19, 4056-4063. 
  
 61 
Bradley, J. S., Jr., Parr, E. J. & Sharkey, K. A. (1997). Effects of inflammation on
 cell proliferation in the myenteric plexus of the guinea-pig ileum. Cell
 Tissue Research, 289, 455-461. 
  
Branchek, T. A. & Gershon, M. D. (1989). Time course of expression of
 neuropeptide Y, calcitonin gene-related peptide, and NADPH diaphorase
 activity in neurons of the developing murine bowel and the appearance of
 5-hydroxytryptamine in mucosal enterochromaffin cells. Comparative
 Neurology, 285, 262-273. 
  
Burns, A. J. (2007). Disorders of interstitial cells of Cajal. Journal of Pediatric
 Gastroenterology, 45, S103-S106. 
  
Burns, A. J. (2007). Migration of neural crest-derived enteric nervous system
 precursor cells to and within the gastrointestinal tract. International Journal
 of Developmental Biology, 49, 143-150.  
  
Burns, A. J. & Delalande, J. M. (2005). Neural crest cell origin for intrinsic ganglia
 of the developing chicken lung. Developmental Biology, 277, 63-79. 
  
Burns, A.J. & Le Douarin, N. M. (1998). The sacral neural crest contributes
 neurons and glia to the post-umbilical gut: spatiotemporal analysis of the
 development of the enteric nervous system. Development, 125, 4335
 4347. 
  
Bush, T. G., Savidge, T. C., Freeman, T. C., Cox, H. J., Campbell, E. A., Mucke,
 L., … Sofroniew M. V. (1998) Fulminant jejuno-ileitis following ablation of
 enteric glia in adult transgenic mice. Cell, 93, 189-201. 
  
Cabarrocas, J., Savidge, T. C., Liblau, R. S. (2003). Role of enteric glial cells in
 inflammatory bowel disease. Glia, 41, 81-93.  
  
Camilleri, M. & Choi, M. G. (1997). Review article: irritable bowel syndrome.
 Alimentary Pharmacology & Therapeutics, 11, 3-15. 
 
Carniti, C., Belluco, S., Riccardi, E., Cranston, A. N., Mondellini, P., Ponder, B.
 A., …Bongarzone, I. (2006). The Ret(C620R) mutation affects renal and
 enteric development in a mouse model of Hirschsprung’s disease.
 American Journal of Pathology, 168, 1262–1275. 
   
Chakravarti, A. (2001). The Metabolic and Molecular Basis of Inherited Diseases.
 New York, New York: McGraw-Hill. 
  
 62 
Chalazonitis, A., Rothman, T. P., Chen, J. & Gershon, M. D. (1998). Age
 dependent differences in the effects of GDNF and NT-3 on the
 development of neurons and glia from neural crest-derived precursors
 immunoselected from the fetal rat gut: expression of GFRalpha-1 in vitro
 and in vivo. Developmental Biology, 204, 385-406. 
  
Chandrasekharan, B. & Srinivasan, S. (2007) Diabetes and the enteric nervous
 system. Neurogastroenterology & Motility, 19, 951-960. 
  
Clarke, L. E. & Barres, B. A. (2013). Emerging roles of astrocytes in neural circuit
 development. Nature Reviews Neuroscience. 14, 311–321. 
  
Collins, S. M., McHugh K., Jacobson K., Khan I., Riddell R., Murase K. &
 Weingarten H. P. (1996). Previous inflammation alters the response of the
 rat colon to stress. Gastroenterology, 111, 1509-1515. 
  
Collins, S. M., Surette, M. & Bercik, P. (2012) The interplay between the
 intestinal microbiota and the brain. Nature Reviews Microbiology, 10, 735
 742. 
  
Cowen, T., Johnson, R. J., Soubeyre, V. & Santer, R. M. (2000). Restricted diet
 rescues rat enteric motor neurons from age related cell death. Gut, 47,
 653-660. 
  
Creamer, B., Shorter, R. G. & Bamforth, J. (1961). Gut, 2, 110-118.  
  
De Giorgio, R., Guerrini, S., Barbara, G., Cremon, C., Stanghellini, V. &
 Corinaldesi, R. New insights into human enteric neuropathies. (2004).
 Neurogastroenterology & Motility, 16, 143-147. 
 
de Graaff, E., Srinivas, S., Kilkenny, C., D’Agati, V., Mankoo, B. S., Constantini,
 F. & Pachnis, V. (2001). Differential activities of the RET tyrosine kinase
 receptor isoforms during mammalian embryogenesis. Genes
 Development, 15, 2433–2444. 
  
de Souza, R. R., Moratelli, H. B., Borges, N. & Liberti, E. A. (1993). Age-induced
 nerve cell loss in the myenteric plexus of the small intestine in man.
 Gerontology, 39, 183-188. 
  
DiNardo, N. G., Blandizzi, C., Volta, U., Colucci, R., Stanghellini, V., Barbara, G.,
 … De, G.R. (2008). Review article: molecular, pathological and
 therapeutic features of human enteric neuropathies. Alimentary
 Pharmacology & Therapeutics, 28, 25-42. 
  
 63 
Drossman, D. A. (1999). Review article: an integrated approach to the irritable
 bowel syndrome. Alimentary Pharmacology & Therapeitocs, 13, 3-14. 
  
Druckenbrod, N. R. & Epstein, M. L. (2005). The pattern of neural crest advance
 in the cecum and colon. Developmental Biology, 287, 125-133. 
  
Durbec, P. L., Larsson-Blomberg, L. B., Schuchardt, A., Costantini, F. & Pachnis,
 V. (1996). Common origin and developmental dependence on c-ret of
 subsets of enteric and sympathetic neuroblasts. Development, 122, 349
 358.  
  
Dyachuk, V., Furlan, A., Shahidi, M. K., Giovenco, M., Kaukua, N.,
 Konstantinidou, C., … Adameyko, I. (2014). Neurodevelopment.
 Parasympathetic neurons originate from nerve-associated peripheral glial
 progenitors. Science, 345, 82-87.  
  
El-Salhy, M., Sandstrom, O. & Holmlund, F. Age-induced changes in the enteric
 nervous system in the mouse. Mechanisms of Ageing and Development,
 107, 93-103. 
  
Erspamer, V., Heffter, A., Heubner, W., Schüller, J., Eichler, O., Farah, A.,
 …Bock, J. C. (1966). 5-Hydroxytryptamine and related indolealkylamines:
 Springer, Berlin. 
  
Espinosa-Medina, I., Outin, E., Picard, C. A., Chettouch, Z., Dymecki, S.,
 Consalez, G. G., … Brunet, J. F. (2014). Neurodevelopment.
 Parasympathetic ganglia derive from Schwann cell precursors. Science,
 345, 87-90.  
  
Fang, S., Wu, R. & Christensen, J. (1993). Intramucosal nerve cells in human
 small intestine. Autonomic Nervous System, 44, 129-136. 
  
Feher, E. & Penzes, L. (1987). Density of substance P, vasoactive intestinal
 polypeptide and somatostatin-containing nerve fibers in the ageing small
 intestine of the rats. Gerontology, 33, 341-348.  
  
Firth, M. & Prather, C. M. (2002) Gastrointestinal motility problems in the elderly
 patient. Gastroenterology, 122, 1688-1700. 
 
Flynn, B., Bergner, A. J., Turner, K. N., Young, H. M. & Anderson, R. B. (2007).
 Effect of Gdnf haploinsufficiency on rate of migration and number of
 enteric neural crest-derived cells. Developmental Dynamics, 236, 134
 141. 
  
 64 
Furness, J. B. (2006). The Enteric Nervous System. Oxford, UK: Blackwell. 
  
Furness, J. B. (2008). The enteric nervous system: normal functions and enteric
 neuropathies. Neurogastroenterology & Motility, 20, 32-38. 
  
Furness, J. B. (2000). Types of neurons in the enteric nervous system.
 Autonomic Nervous System, 81, 87-96. 
  
Furness, J. B. & Costa, M. (1987) The Enteric Nervous System. Edinburgh:
 Churchill Livingstone. 
  
Galligan, J. J. & Parkman, H. (2007). Recent advances in understanding the role
 of serotonin in gastrointestinal motility and functional bowel disorders.
 Neurogastroenterology & Motility, 19, 1-4. 
  
Geboes, K. & Collins, S. (1998). Structural abnormalities of the nervous system
 in Crohn’s disease and ulcerative colitis. Neurogastroenterology & Motility,
 10, 189-202. 
  
Gershon, M. D. (1999). The enteric nervous system: A second brain. Hospital
 Practice, 34(7), 31-42. 
  
Gershon, M. D. & Ratcliffe, E. M. (2006). Development of the enteric nervous
 system. In: Physiology of the gastrointestinal tract (pp. 499
 521). Burlington, MA: Elsevier Academic. 
  
Gershon, M. D. & Rothman, T. P. (1991). Enteric glia. Glia, 4, 195-204. 
  
Gershon, M.D. & Tack, J. (2007). Review: The serotonin signaling system: from
 basic understanding to drug development for functional GI disorders.
 Gastroenterology, 32, 397-414. 
 
Gianino, S., Grider, J. R., Cresswell, J., Enomoto, H. & Heuckeroth, R. O. (2003).
 GDNF availability determines enteric neuron number by controlling
 precursor proliferation. Development, 130, 2187–2198. 
  
Goto, K., Kato, G., Kawahara, I., Luo, Y., Obata, K., Misawa, H., … Takaki, M.
 (2013). In Vivo Imaging of Enteric Neurogenesis in the Deep Tissue of
 Mouse Small Intestine. PLoS ONE, 8(1), e54814. 
  
Gulbransen, B.D. & Sharkey, K.A. (2012). Novel functional roles for enteric glia in
 the gastrointestinal tract. Nature Reviews Gastroenterology & Hepatology,
 9, 625–632. 
  
 65 
Heanue, T. A. & Pachnis, V. (2007). Enteric nervous system development and
 Hirschsprung’s disease: advances in genetic and stem cell studies. Nature
 Reviews Neuroscience, 8, 466-479. 
  
Henning, S. J. (1981). Postnatal development: coordination of feeding, digestion,
 and metabolism. American Journal of Physiology, 241(3), G199-G214.  
  
Hofstra, R. M., Wu, Y., Stulp, R. P., Elfferich, P., Osinga, J., Maas S. M., …
 Buys, C. H. (2000). RET and GDNF gene scanning in Hirschsprung
 patients using two dual denaturing gel systems. Human Mutation, 15, 418
 429. 
 
Hosoda, K., Hammer, R. E., Richardson, J. A., Baynash, A. G., Cheung, J. C.,
 Giaid, A. & Yanagisawa, M. (1994). Targeted and natural (piebald-lethal)
 mutations of endothelin-B receptor gene produce megacolon associated
 with spotted coat color in mice. Cell, 79, 1267–1276. 
  
Jaegle, M., Ghazvini, M., Mandemakers, W., Piirsoo, M., Driegen, S.,
 Levavasseur, F., … Meijer, D. (2003). The POU proteins Brn-2 and Oct-6
 share important functions in Schwann cell development. Genes &
 Development, 17, 1380-1391. 
 
Jain, S., Encinas, M., Johnson, E. M. Jr & Milbrandt, J. (2006). Critical and
 distinct roles for key RET tyrosine docking sites in renal development.
 Genes Development, 20, 321–333. 
  
Jensen, C. J., Massie, A. & De Keyser J. (2013). Immune players in the CNS: the
 astrocyte. Journal of Neuroimmune Pharmacology, 8, 824–839.  
  
Jiang, Y., Liu, M. T. & Gershon, M. D. (2003). Netrins and DCC in the guidance
 of migrating neural crest-derived cells in the developing bowel and
 pancreas. Developmental Biology, 258, 364-384. 
  
Joseph, N. M., He, S., Quintana, E., Kim, Y. G., Nunez, G. & Morrison, S. J.
 (2011). Enteric glia are multipotent in culture but primarily form glia in the
 adult rodent gut. Journal of Clinical Investigation, 121, 3398–3411. 
  
Kabourdis, P. S., Lasrado, R., McCallum, S., Chng S. H., Snippert, H. J.,
 Clevers, H., … Pachnis, V. (2015). Microbiota controls the homeostasis of
 glial cells in the gut lamina propria. Neuron, 85, 289-295. 
  
Kim, J., Lo, L., Dormand, E. & Anderson, D. J. (2003). SOX10 maintains
 multipotency and inhibits neuronal differentiation of neural crest stem
 cells. Neuron, 38, 17-31. 
 66 
  
Kriegstein, A. & Alvarez-Buylla, A. (2009). The glial nature of embryonic and
 adult neural stem cells. Annual Review of Neuroscience, 32, 149-184. 
  
Kruger, G. M., Mosher, J. T., Bixby, S., Joseph, N., Iwashita, T. & Morrison, S. J.
 (2002). Neural crest stem cells persist in the adult gut but undergo
 changes in self-renewal, neuronal subtype potential, and factor
 responsiveness. Neuron, 35, 657–669. 
  
Kulkarni, S., Leser, J., Saha, M., Micci, M., Song, J. & Pasricha, P. J. (2015). 751
 Collagen IV-Pten Signaling Regulates Adult Enteric Neurogenesis In Vitro
 and In Vivo. Gastroenterology, 148(4), S142. 
  
Lakhan, S. E. & Kirchgessner, A. (2010) Neuroinflammation in inflammatory
 bowel disease. Journal of Neuroinflammation, 7, 37. 
  
Laranjeira, C., Sandgren, K., Kessaris, N., Richardson, W., Potocnik, A., Vanden
 Berghe, P. & Pachnis, V. (2011). Glial cells in the mouse enteric nervous
 system can undergo neurogenesis in response to injury. Journal of Clinical
 Investigation, 121, 3412–3424. 
  
Lebouvier, T., Chaumette, T., Paillusson, S., Duyckaerts, C., Bruley, d., V,
 Neunlist, M. & Derkinderen P. (2009). The second brain and Parkinson’s
 disease. European Journal of Neuroscience, 30, 735-741. 
  
Le Douarin, N. M. (1980). The ontogeny of the neural crest in avian embryo
 chimaeras. Nature, 286, 663-669. 
  
Le Douarin, N. M. & Kalcheim, C. (1999). The Neural Crest, Ed 2. Cambridge,
 UK: Cambridge UP. 
  
Le Douarin,  N. M. & Teillet, M. A. (1973). The migration of neural crest cells to
 the wall of the digestive tract in avian embryo. Journal of Embryology and
 Experimental Morphology, 30, 31-48. 
 
Leibl, M. A., Ota, T., Woodward, M. N., Kenny, S. E., Lloyd, D. A., Vaillant, C. R.
 & Edgar, D. H. (1999). Expression of endothelin 3 by mesenchymal cells
 of embryonic mouse caecum. Gut, 44, 246–252. 
  
Lin, A., Lourenssen, S., Stanzel, R. D. & Blennerhassett, M. G. (2005). Selective
 loss of NGFsensitive neurons following experimental colitis. Experimental
 Neurology, 191, 337-343. 
  
 67 
Lindley, R. M., Hawcutt, D. B., Connell, M. G., Almond, S. N., Vannucchi, M. G.,
 Faussone-Pellegrini, M. S., … Kenny, S. E. (2008). Human and mouse
 enteric nervous system neurosphere transplants regulate the function of
 aganglionic embryonic distal colon. Gastroenterology, 135, 205–216. 
  
Liu, M. T., Kuan, Y. H., Wang, J., Hen, R. & Gershon, M. D. (2009). 5-HT4
 receptor-mediated neuroprotection and neurogenesis in the enteric
 nervous system of adult mice. Journal of Neuroscience, 29, 9683-9699. 
  
Liu, Y.A., Chung, Y.C., Pan, S.T., Shen, M.Y., Hou, Y.C., Peng, S.J., Pasricha,
 P.J. & Tang, S.C. (2013). 3-D imaging, illustration, and quantitation of
 enteric glial network in transparent human colon mucosa.
 Neurogastroenterology & Motility, 25, e324–e338. 
  
Maehama, T. & Dixon, J. E. (1998). The tumor suppressor, PTEN/MMAC1,
 dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5
 trisphosphate. Journal of Biological Chemistry, 273, 13375–13378. 
  
Margolis, K. G. & Gershon, M. D. (2009). Neuropeptides and inflammatory bowel
 disease. Current Opinion in Gastroenterology, 25, 503-511. 
  
Martignoni, E., Pacchetti, C., Godi, L., Micieli, G. & Nappi, G. (1995). Autonomic
 disorders in Parkinson’s disease. Journal of Neural Transmission.
 Supplementa, 45, 11-19. 
  
Matini, P., Mayer, B. & Faussone-Pellegrini, M. S. (1997). Neurochemical
 differentiation of rat enteric neurons during pre- and postnatal life. Cell
 Tissue Research, 288, 11-23. 
  
Matsuoka, T., Ahlberg, P. E., Kessaris, N., Iannarelli, P., Dennehy, U.,
 Richardson, W. D., … Koentges, G. (2005). Neural crest origins of the
 neck and shoulder. Nature, 436, 347–355. 
  
Mawe, G. M., Collins, S. M. & Shea-Donohue, T. (2004). Changes in enteric
 neural circuitry and smooth muscle in the inflamed and infected gut.
 Neurogastroenterology & Motility, 16, 133-136. 
  
Merkle, F.T., Tramontin, A. D., Garcia-Verdugo, J. M. & Alvarez-Buylla, A.
 (2004). Radial glia give rise to adult neural stem cells in the subventricular
 zone. Proceedings of the National Academy of Sciences, 101, 17528
 17532. 
  
 68 
Metzger, M., Caldwell, C., Barlow, A. J., Burns, A. J. & Thapar, N. (2009). Enteric
 nervous system stem cells derived from human gut mucosa for the
 treatment of aganglionic gut disorders. Gastroenterology, 136, 2214-2225. 
  
Metzger, M. (2010). Neurogenesis in the enteric nervous system. Archives
 Italiennes de Biologie, 148, 73-83. 
   
Nasser, Y., Fernandez, E., Keenan, C. M., Ho, W., Oland, L. D., Tibbles, L. A., …
 Sharkey, K. A. (2006). Role of enteric glia in intestinal physiology: effects
 of the gliotoxin fluorocitrate on motor and secretory function. American
 Journal of Physiology & Gastrointestinal Liver Physiology, 291, G912-927. 
 
Natarajan, D., Marcos-Gutierrez, C., Pachnis, V. & de Graaff, E. (2002).
 Requirement of signaling by receptor tyrosine kinase RET for the directed
 migration of enteric nervous system progenitor cells during mammalian
 embryogenesis. Development, 129, 5151–5160. 
  
Neal, K. R., Hebden, J. & Spiller, R. (1997). Prevalence of gastrointestinal
 symptoms six months after bacterial gastroenteritis and risk factors for
 development of the irritable bowel syndrome: postal survey of patients.
 BMJ, 314, 779-782. 
  
Newgreen, D. & Young, H. M. (2002). Enteric nervous system: development and
 developmental disturbances- part 1. Pediatric Developmental Pathology,
 5, 224-247. 
  
Obermayr, F., Hotta, R., Enomoto, H. & Young , H. M. (2013). Development and
 developmental disorders of the enteric nervous system. National Review
 of Gastroenterology & Hepatology, 10, 43-57.  
  
Okamura, Y. & and Saga, Y. (2008). Notch signaling is required for the
 maintenance of enteric neural crest progenitors. Development, 135, 555
 3565. 
  
Organization of the enteric nervous system. (2015). [Image]. Retrieved from
 http://clinicalgate.com/gastrointestinal-hormones-and-neurotransmitters/ 
  
Paratore, C., Eichenberger, C., Suter, U. & Sommer, L. (2002). Sox10
 haploinsufficiency affects maintenance of progenitor cells in a mouse
 model of Hirschsprung disease. Human Molecular Genetics, 11, 3075
 3085. 
  
 69 
Parmantier, E., Lynn, B., Lawson, D., Turmaine, M., Namini, S. S., Chakrabarti,
 L., … Mirsky, R. (1999). Schwann cell-derived Desert hedghog conrols the
 development of peripheral nerve sheaths. Neuron, 23, 713-724.  
  
Pfeiffer, R. F. (1998). Gastrointestinal dysfunction in Parkinson’s disease. Clinical
 Neuroscience., 5, 136-146. 
  
Pham, T. D., Gershon, M. D. & Rothman, T. P. (1991). Time of origin of neurons
 in the murine enteric nervous system: sequence in relation to phenotype.
 Journal of Comparative Neurology, 314, 789-798. 
  
Phillips, R. J., Kieffer, E. J. & Powley, T. L. (2003). Aging of the myenteric plexus:
 neuronal loss is specific to cholinergic neurons. Autonomic Neuroscience,
 106, 69-83. 
  
Phillips, R. J., Kieffer, E. J. & Powley, T. L. (2004). Loss of glia and neurons in
 the myenteric plexus of the aged Fischer 344 rat. Anatomical Embryology,
 209, 19-30. 
  
Phillips, R. J., Powley, T. L. (2001). As the gut ages: timetables for aging of
 innervation vary by organ in the Fischer 344 rat. Journal of Comparative
 Neurology, 434, 358–377. 
 
Plaza-Menacho, I., Burzynski, G. M., de Groot, J. W., Eggen, B. J. & Hofstra, R.
 M. (2006). Current concepts in RETrelated genetics, signaling and
 therapeutics. Trends Genetic, 22, 627–636. 
  
Puig, I., Champeval, D., De Santa Barbara, P., Jaubert, F., Lyonnet, S. & Larue,
 L. (2009). Deletion of Pten in the mouse enteric nervous system induces
 ganglioneuromatosis and mimics intestinal pseudoobstruction. Journal of
 Clinical Investigation, 119, 3586–3596. 
  
Rauch, U., Hansgen, A., Hagl, C., Holland-Cunz, S. & Schafer, K. H. (2006).
 Isolation and cultivation of neuronal precursor cells from the developing
 human enteric nervous system as a tool for cell therapy in
 dysganglionosis. International Journal of Colorectal Disease, 21, 554-559. 
  
Reynolds, B. A. & Weiss, S. (1992). Generation of neurons and astrocytes from
 isolated cells of the adult mammalian central nervous system. Science,
 255, 1707-1710. 
  
Ruhl, A. (2005). Glial cells in the gut. Neurogastroenterology & Motility, 17, 777
 790. 
  
 70 
Ruhl, A., Nasser, Y. & Sharkey, K. A. (2004). Enteric glia. Neurogastroenterology
 & Motility, 16(1), 44–49. 
  
Schafer, K. H., Van, G. C. & Copray, S. (2009). Plasticity and neural stem cells in
 the enteric nervous system. The Anatomical Record (Hoboken), 292,
 1940-1952. 
 
Schuchardt, A., D’Agati, V., Larsson-Blomberg, L., Costantini, F. & Pachnis, V.
 (1994). Defects in the kidney and enteric nervous system of mice lacking
 the tyrosine kinase receptor Ret. Nature, 367, 380–383. 
  
Sharkey, K. A. & Kroese, A. B. (2001). Consequences of intestinal inflammation
 on the enteric nervous system: neuronal activation induced by
 inflammatory mediators. Anatomical Record, 262, 79–90. 
 
Shepherd, I. T., Pietsch, J., Elworthy, S., Kelsh, R. N. & Raible, D. W. (2004).
 Roles for GFRα1 receptors in zebrafish enteric nervous system
 development. Development, 131, 241–249. 
 
Shin, M. K., Levorse, J. M., Ingram, R. S. & Tilghman, S. M. (1999). The
 temporal requirement for endothelin receptor-B signalling during neural
 crest development. Nature, 402, 496–501. 
  
Skaper, S. D., Facci, L. & Giusti, P. (2014). Mast cells, glia and
 neuroinflammation: partners in crime? Immunology, 141, 314–327. 
  
Spiller, R. C. (2003). Infection as a cause of irritable bowel syndrome. Hospital
 Medicine, 64, 270-274. 
  
Stiles, B., Groszer, M., Wang, S., Jiao, J. & Wu, H. (2004). PTENless means
 more. Developmental Biology 273, 175–184. 
  
Swenson, O. (2002). Hirschsprung's disease: a review. Pediatrics, 109, 914-918. 
 
Takahashi, M. (2001). The GDNF/RET signaling pathway and human diseases.
 Cytokine Growth Factor Review, 12, 361–373. 
  
Takaki, M., Goto, K. & Kawahara, I. (2014). The 5-hydroxytryptamine 4 receptor
 agonist-induced actions and enteric neurogenesis in the gut.
 Neurogastroenterology & Motility, 20(1), 17-30. 
  
Taraviras, S., Marcos-Gutierrez, C. V., Durbec, P., Jani, H., Grigoriou, M.,
 Sukumaran, M., … Pachnis, V. (1999). Signalling by the RET receptor
 71 
 tyrosine kinase and its role in the development of the mammalian enteric
 nervous system. Development, 126, 2785-2797.  
  
Thrasivoulou, C., Soubeyre, V., Ridha, H., Giuliani, D., Giaroni, C., Michael, G.
 J., … Cowen, T. (2006). Reactive oxygen species, dietary restriction and
 neurotrophic factors in age-related loss of myenteric neurons. Aging Cell,
 5, 247-257. 
  
Toumi, F., Neunlist, M., Cassagnau, E., Parois, S., Laboisse, C.L., Galmiche,
 J.P. & Jarry, A. (2003). Human submucosal neurones regulate intestinal
 epithelial cell proliferation: evidence from a novel co-culture model.
 Neurogastroenterology & Motility, 15, 239-242. 
  
Tramontin, A. D., Garcia-Verdugo, J. M., Lim, D. A. & Alvarez-Buylla, A. (2003).
 Postnatal development of radial glia and the ventricular zone (VZ); a
 continuum of the neural stem cell compartment. Cerebral Cortex, 13, 580
 587. 
  
Uesaka, T., Nagashimada, M. & Enomoto, H. (2015). Neuronal Differentiation in
 Schwann Cell Lineage Underlies Postnatal Neurogenesis in the Enteric
 Nervous System. The Journal of Neuroscience, 35(27), 9879-9888. 
  
Van Ginneken, G. C., van Meir, M. F., Sys, S. & Weyns, A. (2001). Stereologic
 description of the changing expression of constitutive nitric oxide synthase
 and heme oxygenase in the enteric plexuses of the pig small intestine
 during development. Journal of Comparative Neurology, 437, 118-128. 
  
Vannucchi, M. G. & Faussone-Pellegrini, M. S. (1996). Differentiation of
 cholinergic cells in the rat gut during pre- and postnatal life. Neuroscience
 Letter, 206, 105-108. 
  
Veiga-Fernandes, H., Coles, M. C., Foster, K. E., Patel, A., Williams, A.,
 Natarajan, D., … Kioussis, D. (2007). Tyrosine kinase receptor RET is a
 key regulator of Peyer's patch organogenesis. Nature, 446, 547-551. 
  
Verkhratsky, A. & Butt, A. (2007). Glial Neurobiology, A Textbook. John Wiley &
 Sons. 
  
von Boyen, G. B., Steinkamp, M., Reinshagen, M., Schafer, K. H., Adler G. &
 Kirsch J. (2004). Proinflammatory cytokines increase glial fibrillary acidic
 protein expression in enteric glia. Gut, 53, 222-228. 
  
 72 
Wade, P. R. (2002). Aging and neural control of the GI tract. I. Age-related
 changes in the enteric nervous system. American Journal of
 Gastrointestinal Liver Physiology, 283, G489-G495. 
  
Wade, P.R. & Cowen, T. (2004). Neurodegeneration: a key factor in the ageing
 gut. Neurogastroenterology & Motility, 16, 19-23. 
  
Widera, D., Heimann, P., Zander, C., Imileski, Y., Heidbreder, M., Heilemann, M.,
 … Katschmidt, B. (2011). Schwann cells can be reprogrammed to
 multipotency by culture. Stem Cells and Development, 20, 2053-2064.  
 
Wong, A., Bogni, S., Kotka, P., de Graaff, E., D’Agati, V., Costantini, F. &
 Pachnis, V. (2005). Phosphotyrosine 1062 is critical for the in vivo activity
 of the Ret9 receptor tyrosine kinase isoform. Molecular and Cellular
 Biology, 25, 9661–9673. 
  
Wood, J. D. & Grundy, D. (1998). Little brain - big brain V.
 Neurogastroenterology & Motility, 10, 377-385. 
 
Yanagisawa, H., Yanagisawa, M., Kapur, R. P., Richardson, J. A., Williams, S.
 C., Clouthier, D. E., …Hammer, R. E. (1998). Dual genetic pathways of
 endothelin-mediated intercellular signaling revealed by targeted disruption
 of endothelin converting enzyme-1 gene. Development, 125, 825–836. 
  
Young, H. M., Bergner, A. J. & Muller, T. (2003). Acquisition of neuronal and glial
 markers by neural crest-derived cells in the mouse intestine. Journal of
 Comparative Neurology, 456, 1-11. 
  
Young H. M., Bergner, A. J., Anderson, R. B., Enomoto, H., Milbrandt, J.,
 Newgreen, D. F. & Whitington, P. M. (2004). Dynamics of neural crest
 derived cell migration in the embryonic mouse gut. Developmental
 Biology, 270, 455-473. 
  
Young, H. M., Ciampoli, D., Hsuan, J. & Canty, A. J. (1999). Expression of Ret-,
 p75(NTR)-, Phox2a-, Phox2b-, and tyrosine hydroxylase-immunoreactivity
 by undifferentiated neural crest-derived cells and different classes of
 enteric neurons in the embryonic mouse gut. Developmental Dynamics,
 216, 137-152. 
 
Young, H. M., Hearn, C. J., Farlie, P. G., Canty, A. J., Thomas P. Q. &
 Newgreen, D. F. (2001). GDNF is a chemoattractant for enteric neural
 cells. Developmental Biology, 229, 503–516. 
  
 73 
Young, H. M., Turner, K. N. & Bergner, A. J. (2005). The location and phenotype
 of proliferating neural-crest-derived cells in the developing mouse gut. Cell
 Tissue Research, 320, 1-9. 
  
Zong, H., Espinosa, J. S., Su, H. H., Muzumdar, M. D., & Luo, L. (2005). Mosaic
 analysis with double markers in mice. Cell 121, 479–492. 
  
 74 
                                          
 75 
 
 
 
 76 
 
 
  
 
